BACKGROUND Convalescent plasma is the only antibody-based therapy currently available for patients with coronavirus disease 2019 (COVID-19). It has robust historical precedence and sound biological plausibility. Although promising, convalescent plasma has not yet been shown to be safe as a treatment for COVID-19.METHODS Thus, we analyzed key safety metrics after transfusion of ABO-compatible human COVID-19 convalescent plasma in 5000 hospitalized adults with severe or life-threatening COVID-19, with 66% in the intensive care unit, as part of the US FDA expanded access program for COVID-19 convalescent plasma.RESULTS The incidence of all serious adverse events (SAEs), including mortality rate (0.3%), in the first 4 hours after transfusion was <1%. Of the 36 reported SAEs, there were 25 reported incidences of related SAEs, including mortality (n = 4), transfusion-associated circulatory overload (n = 7), transfusion-related acute lung injury (n = 11), and severe allergic transfusion reactions (n = 3). However, only 2 of 36 SAEs were judged as definitely related to the convalescent plasma transfusion by the treating physician. The 7-day mortality rate was 14.9%.CONCLUSION Given the deadly nature of COVID-19 and the large population of critically ill patients included in these analyses, the mortality rate does not appear excessive. These early indicators suggest that transfusion of convalescent plasma is safe in hospitalized patients with COVID-19.TRIAL REGISTRATION ClinicalTrials.gov NCT04338360.FUNDING Mayo Clinic, Biomedical Advanced Research and Development Authority (75A50120C00096), National Center for Advancing Translational Sciences (UL1TR002377), National Heart, Lung, and Blood Institute (5R35HL139854 and R01 HL059842), National Institute of Diabetes and Digestive and Kidney Diseases (5T32DK07352), Natural Sciences and Engineering Research Council of Canada (PDF-532926-2019), National Institute of Allergy and Infectious Disease (R21 AI145356, R21 AI152318, and AI152078), Schwab Charitable Fund, United Health Group, National Basketball Association, Millennium Pharmaceuticals, and Octapharma USA Inc.
Michael J. Joyner, R. Scott Wright, DeLisa Fairweather, Jonathon W. Senefeld, Katelyn A. Bruno, Stephen A. Klassen, Rickey E. Carter, Allan M. Klompas, Chad C. Wiggins, John R.A. Shepherd, Robert F. Rea, Emily R. Whelan, Andrew J. Clayburn, Matthew R. Spiegel, Patrick W. Johnson, Elizabeth R. Lesser, Sarah E. Baker, Kathryn F. Larson, Juan G. Ripoll, Kylie J. Andersen, David O. Hodge, Katie L. Kunze, Matthew R. Buras, Matthew N.P. Vogt, Vitaly Herasevich, Joshua J. Dennis, Riley J. Regimbal, Philippe R. Bauer, Janis E. Blair, Camille M. Van Buskirk, Jeffrey L. Winters, James R. Stubbs, Nigel S. Paneth, Nicole C. Verdun, Peter Marks, Arturo Casadevall
Title and authors | Publication | Year |
---|---|---|
Post-transfusion activation of coagulation pathways during severe COVID-19 correlates with COVID-19 convalescent plasma antibody profiles
Svenja Weiss, Hung-Mo Lin, Eric Acosta, Natalia L Komarova, Ping Chen, Dominik Wodarz, Ian Baine, Ralf Duerr, Ania Wajnberg, Adrian Gervais, Paul Bastard, Jean-Laurent Casanova, Suzanne A Arinsburg, Talia H. Swartz, Judith A. Aberg, Nicole M. Bouvier, Sean T. H. Liu, Raymond A. Alvarez, Benjamin K. Chen |
Journal of Clinical Investigation | 2025 |
Coagulation Profile of Convalescent Plasma Donors and Recipients
Pitkänen HH, Helin T, Khawaja T, Pietilä JP, Kajova M, Välimaa H, Vahlberg T, Ihalainen J, Vierikko A, Vapalahti O, Kantele A, Lassila R |
Clinical and Applied Thrombosis/Hemostasis | 2025 |
COVID-19 clinical presentation, management, and epidemiology: a concise compendium
Maison DP, Tasissa H, Deitchman A, Peluso MJ, Deng Y, Miller FD, Henrich TJ, Gerschenson M |
Frontiers in Public Health | 2025 |
Convalescent Plasma as Adjunctive Therapy for Hospitalized Patients with COVID-19: The Co-CLARITY Trial
Gauiran DT, Dumagay TE, Ang MA, Dungog CC, Climacosa FM, Maganito SC, Alfonso RN, Quero AK, Lucero JA, Cortez CF, Evasan AL, King RA, Heralde FM, Bonifacio LB, Castillo GJ Jr, Escasa IM, Santos MC, Malundo AF, Mondragon AV, Salamat SE, Veloso JD, Carnate JM Jr, Tagayuna PY, Lim JA, Alejandria MM, Mirasol MA |
2024 | |
Immunization against Medically Important Human Coronaviruses of Public Health Concern
Nimer NA, Nimer SN |
2024 | |
Preclinical and Clinical Investigations of Potential Drugs and Vaccines for COVID-19 Therapy: A Comprehensive Review With Recent Update.
Mia ME, Howlader M, Akter F, Hossain MM |
2024 | |
Avoided and Avoidable Deaths with the Use of COVID-19 Convalescent Plasma in Italy during the First Two Years of Pandemic
Franchini M, Casadevall A, Dragotakes Q, Focosi D |
Life | 2024 |
Estimates of actual and potential lives saved in the United States from the use of COVID-19 convalescent plasma.
Dragotakes Q, Johnson PW, Buras MR, Carter RE, Joyner MJ, Bloch E, Gebo KA, Hanley DF, Henderson JP, Pirofski LA, Shoham S, Senefeld JW, Tobian AAR, Wiggins CC, Wright RS, Paneth NS, Sullivan DJ, Casadevall A, Dragotakes Q, Johnson PW, Buras MR, Carter RE, Joyner MJ, Bloch E, Gebo KA, Hanley DF, Henderson JP, Pirofski LA, Shoham S, Senefeld JW, Tobian AAR, Wiggins CC, Wright RS, Paneth NS, Sullivan DJ, Casadevall A |
Proceedings of the National Academy of Sciences of the United States of America | 2024 |
Profile of Arturo Casadevall.
Williams SCP |
Proceedings of the National Academy of Sciences of the United States of America | 2024 |
Retrospective Analysis of Coronavirus SARS-CoV-2 Antibody Levels in COVID-19 Convalescent Plasma From Blood Donors
He J, Zhang Y, Dong J, Zhang W, Zhu F |
The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien des Maladies Infectieuses et de la Microbiologie Médicale | 2024 |
Convalescent plasma (hyperimmune immunoglobulin) for COVID-19 management: An update
Chavda VP, Bezbaruah R, Dolia S, Shah N, Verma S, Savale S, Ray S |
2023 | |
Protective roles and protective mechanisms of neutralizing antibodies against SARS-CoV-2 infection and their potential clinical implications
Abebe EC, Dejenie TA |
Frontiers in immunology | 2023 |
Evaluation of Convalescent Plasma in the Management of Critically Ill COVID-19 Patients (with No Detectable Neutralizing Antibodies Nab) in Kashmir, India
Elkhalifa AM, Nabi SU, Shah NN, Dar KA, Quibtiya S, Bashir SM, Ali SI, Taifa S, Hussain I |
Healthcare | 2023 |
Use of COVID-19 Convalescent Plasma for Treatment of Symptomatic SARS-CoV-2 Infection at a Children’s Hospital: A Contribution to a Still Inadequate Body of Evidence
Arrieta A, Galvis AE, Osborne S, Morphew T, Imfeld K, Enriquez C, Hoang J, Swearingen M, Nieves DJ, Ashouri N, Singh J, Nugent D |
Children | 2023 |
Convalescent Plasma Treatment of Patients Previously Treated with B-Cell-Depleting Monoclonal Antibodies Suffering COVID-19 Is Associated with Reduced Re-Admission Rates
Ioannou P, Katsigiannis A, Papakitsou I, Kopidakis I, Makraki E, Milonas D, Filippatos TD, Sourvinos G, Papadogiannaki M, Lydaki E, Chamilos G, Kofteridis DP |
Viruses | 2023 |
High-Throughput Neutralization and Serology Assays Reveal Correlated but Highly Variable Humoral Immune Responses in a Large Population of Individuals Infected with SARS-CoV-2 in the US between March and August 2020
Zhang S, Ma P, Orzechowski M, Lemmer A, Rzasa K, Bagnall J, Barkho S, Chen M, He L, Neitupski R, Tran V, Ackerman R, Gath E, Bond A, Frongillo G, Cleland T, Golas A, Gaca A, Fitzgerald M, Kelly K, Hazegh K, Dumont L, Hoffman C, Homer M, Marks P, Woolley A, Wong S, Gomez J, Livny J, Hung D |
mBio | 2023 |
Severe COVID-19: Drugs and Clinical Trials
Ceja-Gálvez HR, Renteria-Flores FI, Nicoletti F, Hernández-Bello J, Macedo-Ojeda G, Muñoz-Valle JF |
Journal of Clinical Medicine | 2023 |
COVID-19 Serology Data Provide Guidance for Future Deployments of Convalescent Plasma
Sullivan D, Casadevall A |
mBio | 2023 |
Impact of the COVID-19 pandemic on blood donation and transfusions in the United States in 2020
Basavaraju SV, Free RJ, Chavez Ortiz JL, Stewart P, Berger J, Sapiano MR |
Transfusion | 2023 |
Raman Fingerprints of SARS-CoV-2 Omicron Subvariants: Molecular Roots of Virological Characteristics and Evolutionary Directions
Pezzotti G, Ohgitani E, Fujita Y, Imamura H, Pappone F, Grillo A, Nakashio M, Shin-Ya M, Adachi T, Yamamoto T, Kanamura N, Marin E, Zhu W, Inaba T, Tanino Y, Nukui Y, Higasa K, Yasukochi Y, Okuma K, Mazda O |
ACS Infectious Diseases | 2023 |
Navigating the Post-COVID-19 Immunological Era: Understanding Long COVID-19 and Immune Response
Mohan A, Iyer VA, Kumar D, Batra L, Dahiya P |
Life Sciences | 2023 |
Reconstituted extracellular vesicles from human platelets decrease viral myocarditis in mice
Beetler DJ, Bruno KA, Watkins MM, Xu V, Chekuri I, Giresi P, Di Florio DN, Whelan ER, Edenfield BH, Walker SA, Morales-Lara AC, Hill AR, Jain A, Auda ME, Macomb LP, Shapiro KA, Keegan KC, Wolfram J, Behfar A, Stalboerger PG, Terzic A, Farres H, Cooper LT Jr, Fairweather D |
Small (Weinheim an Der Bergstrasse, Germany) | 2023 |
Exercise and Experiments of Nature.
Joyner MJ, Wiggins CC, Baker SE, Klassen SA, Senefeld JW |
Comprehensive Physiology | 2023 |
The VA Research Enterprise: A Platform for National Partnerships Toward Evidence Building and Scientific Innovation
Garcia AP, Huang GD, Arnheim L, Ramoni RB, Clancy CM |
2023 | |
Antibodies from convalescent plasma promote SARS-CoV-2 clearance in individuals with and without endogenous antibody response
Maddalena Marconato, Irene A Abela, Anthony Hauser, Magdalena Schwarzmüller, Rheliana Katzensteiner, Dominique L. Braun, Selina Epp, Annette Audigé, Jacqueline Weber, Peter Rusert, Emèry Schindler, Chloé Pasin, Emily West, Jürg Böni, Verena Kufner, Michael Huber, Maryam Zaheri, Stefan Schmutz, Beat M. Frey, Roger D. Kouyos, Huldrych Günthard, Markus G. Manz, Alexandra Trkola |
Journal of Clinical Investigation | 2022 |
Pharmacokinetics of High-titer Anti-SARS-CoV-2 Human Convalescent Plasma in High-risk Children
Oren Gordon, Mary K. Brosnan, Steve Yoon, Dawoon Jung, Kirsten Littlefield, Abhinaya Ganesan, Christopher A. Caputo, Maggie Li, William Morgenlander, Stephanie N. Henson, Alvaro A. Ordonez, Patricia De Jesus, Elizabeth W. Tucker, Nadine Peart Akindele, Zexu Ma, Jo Wilson, Camilo A. Ruiz-Bedoya, M. Elizabeth M. Younger, Evan M Bloch, Shmuel Shoham, David Sullivan, Aaron A.R. Tobian, Kenneth R. Cooke, Ben Larman, Jogarao Gobburu, Arturo Casadevall, Andrew Pekosz, Howard M Lederman, Sabra Klein, Sanjay K. Jain |
JCI Insight | 2022 |
Convalescent plasma improves overall survival in patients with B-cell lymphoid malignancy and COVID-19: a longitudinal cohort and propensity score analysis
T Hueso, A Godron, E Lanoy, J Pacanowski, L Levi, E Gras, L Surgers, A Guemriche, J Meynard, F Pirenne, S Idri, P Tiberghien, P Morel, C Besson, R Duléry, S Lamure, O Hermine, A Gagneux-Brunon, N Freymond, S Grabar, K Lacombe |
Leukemia | 2022 |
Coagulation profile of human COVID-19 convalescent plasma
A Klompas, N van Helmond, J Juskewitch, R Pruthi, M Sexton, J Soto, S Klassen, K Senese, C van Buskirk, J Winters, J Stubbs, S Hammel, M Joyner, J Senefeld |
Scientific Reports | 2022 |
Convalescent plasma therapy against the emerging SARS-CoV-2 variants: Delineation of the potentialities and risks
M Dhawan, Priyanka, M Parmar, S Angural, O Choudhary |
International journal of surgery (London, England) | 2022 |
Mesenchymal stem cell-based treatments for COVID-19: status and future perspectives for clinical applications
L Chen, J Qu, F Kalyani, Q Zhang, L Fan, Y Fang, Y Li, C Xiang |
Cellular and Molecular Life Sciences | 2022 |
The Role of Disease Severity and Demographics in the Clinical Course of COVID-19 Patients Treated With Convalescent Plasma
T Ma, C Wiggins, B Kornatowski, R Hailat, A Clayburn, W Guo, P Johnson, J Senefeld, S Klassen, S Baker, K Bruno, D Fairweather, R Wright, R Carter, C Li, M Joyner, N Paneth |
Frontiers in Medicine | 2022 |
The “Invisible Enemy” SARS-CoV-2: Viral Spread and Drug Treatment
A Tanase, A Manea, A Scurtu, L Bratu, D Chioran, A Dolghi, I Alexoi, H AAbed, V Lazureanu, C Dehelean |
Medicina | 2022 |
Convalescent Plasma for Preventing Critical Illness in COVID-19: a Phase 2 Trial and Immune Profile
J Sturek, T Thomas, J Gorham, C Sheppard, A Raymond, K Guex, W Harrington, A Barros, G Madden, Y Alkabab, D Lu, Q Liu, M Poulter, A Mathers, A Thakur, D Schalk, E Kubicka, L Lum, S Heysell, U Neogi |
Microbiology spectrum | 2022 |
Convalescent plasma therapy in patients with severe COVID-19, A single-arm, retrospective study
L Ghadami, M Hasibi, A Asadollahi-Amin, B asanjarani, M Farahmand, H Abdollahi |
Microbial Pathogenesis | 2022 |
Severe Cholestatic Hepatitis Secondary to SARS-CoV-2
C Lindholm, X Zhang, E Spengler, K Daniel |
ACG Case Reports Journal | 2022 |
Convalescent plasma in COVID-19: renewed focus on the timing and effectiveness of an old therapy
H Nashaat, M Anani, F Attia |
Blood Research | 2022 |
Immunotherapy and CRISPR Cas Systems: Potential Cure of COVID-19?
X He, X Zeng |
Drug design, development and therapy | 2022 |
THE DARK SIDE OF THE COVID-19 TREATMENTS ON MYCOBACTERIUM TUBERCULOSIS INFECTION
F Maio, D Bianco, G Delogu |
Mediterranean journal of hematology and infectious diseases | 2022 |
Early Outpatient Treatment for Covid-19 with Convalescent Plasma
D Sullivan, K Gebo, S Shoham, E Bloch, B Lau, A Shenoy, G Mosnaim, T Gniadek, Y Fukuta, B Patel, S Heath, A Levine, B Meisenberg, E Spivak, S Anjan, M Huaman, J Blair, J Currier, J Paxton, J Gerber, J Petrini, P Broderick, W Rausch, M Cordisco, J Hammel, B Greenblatt, V Cluzet, D Cruser, K Oei, M Abinante, L Hammitt, C Sutcliffe, D Forthal, M Zand, E Cachay, J Raval, S Kassaye, E Foster, M Roth, C Marshall, A Yarava, K Lane, N McBee, A Gawad, N Karlen, A Singh, D Ford, D Jabs, L Appel, D Shade, S Ehrhardt, S Baksh, O Laeyendecker, A Pekosz, S Klein, A Casadevall, A Tobian, D Hanley |
New England Journal of Medicine | 2022 |
Multiple Routes of Antibody-Dependent Enhancement of SARS-CoV-2 Infection
K Okuya, T Hattori, T Saito, Y Takadate, M Sasaki, W Furuyama, A Marzi, Y Ohiro, S Konno, T Hattori, A Takada, R Medina |
Microbiology spectrum | 2022 |
High-cited favorable studies for COVID-19 treatments ineffective in large trials
J Ioannidis |
Journal of Clinical Epidemiology | 2022 |
Antibody-mediated neutralization of SARS-CoV-2
Gruell H, Vanshylla K, Weber T, Barnes CO, Kreer C, Klein F |
Immunity | 2022 |
COVID-19 : les thérapeutiques
KHERABI Y, LESCURE FX, YAZDANPANAH Y, PEIFFER-SMADJA N |
2022 | |
The Effect of Convalescent Plasma in Patients With Covid-19 in Intensive Care Unit
BEREANU A, CRISAN O, CONSTANTIN AM, CAINAP S, CAINAP C, DRAGULESCU R, BEREANU R, VINTILA B, ROMAN C, SAVA M |
In vivo (Athens, Greece) | 2022 |
COVID-19 management landscape: A need for an affordable platform to manufacture safe and efficacious biotherapeutics and prophylactics for the developing countries
Pidiyar V, Kumraj G, Ahmed K, Ahmed S, Shah S, Majumder P, Verma B, Pathak S, Mukherjee S |
Vaccine | 2022 |
Reinforcement of the Standard Therapy with Two Infusions of Convalescent Plasma for Patients with COVID-19: A Randomized Clinical Trial
Bargay-Lleonart J, Sarubbo F, Arrizabalaga M, Guerra JM, Borràs J, El Haji K, Flexas M, Perales J, Fernández-Baca V, Gallegos C, Cruz MR, Velasco S, López V, Cruz A, Bautista-Gili A, Jimenez-Marco T, Girona-Llobera E, Vilaplana L, Calonge L, Tena J, Galán MP, Payeras A |
Journal of Clinical Medicine | 2022 |
The Role of Antibodies in the Treatment of SARS-CoV-2 Virus Infection, and Evaluating Their Contribution to Antibody-Dependent Enhancement of Infection
Farouq MA, Acevedo R, Ferro VA, Mulheran PA, Al Qaraghuli MM |
International journal of molecular sciences | 2022 |
National Research Institute of Tuberculosis and Lung Disease (NRITLD) Protocol for the Treatment of Patients with COVID-19
Mirenayat MS, Abedini A, Kiani A, Eslaminejad A, Adimi naghan P, Malekmohammad M, Heshmatnia J, Nadji SA, Idani E, Zahiri R, Lookzadeh S, Sheikhzade H, Dastan F, Porabdollah Toutkaboni M, Rezaei MS, Askari E, Tabarsi P, Marjani M, Moniri A, Hashemian SM, Farzanegan B, Abtahian Z, Yassari F, Mansouri N, Mansouri D, Vasheghani M, Mansourafshar B, Mokhber Dezfoli M, Soleimani S, Seifi S, Naghashzadeh F, Fakharian A, Varahram M, Jamaati H, Zali A, Velayati AA |
2022 | |
Serial Convalescent Plasma Infusions for the Initial COVID-19 Infections in the Appalachian Region of West Virginia
Peppers BP, Shmookler A, Stanley J, Giblin Sutton L, Perrotta PL, Kieffer T, Skoner D, Mahady S, Lewandrowski C, Damron H, Horspool A, Sakhjua A, McCarthy P, Hostoffer RW |
Allergy & Rhinology | 2022 |
Abnormal antibodies to self-carbohydrates in SARS-CoV-2-infected patients
Butler DL, Imberti L, Quaresima V, Fiorini C, Gildersleeve JC |
2022 | |
Convalescent plasma therapy for patients with severe COVID-19: A case series study
Huang J, Weng H, Lan C, Li H |
Medicine | 2022 |
Predictors of mortality in COVID-19 patients treated with convalescent plasma therapy
Rahimi-Levene N, Shapira J, Tzur I, Shiloah E, Peer V, Levin E, Izak M, Shinar E, Ziv-Baran T, Weinberger M, Zimhony O, Chen J, Maor Y |
PloS one | 2022 |
COVID-19 Convalescent Plasma and Clinical Trials: Understanding Conflicting Outcomes
Focosi D, Franchini M, Pirofski LA, Burnouf T, Paneth N, Joyner MJ, Casadevall A |
Clinical microbiology reviews | 2022 |
Characterization of pathogen‐inactivated COVID‐19 convalescent plasma and responses in transfused patients
Weisser M, Khanna N, Hedstueck A, Sutter ST, Roesch S, Stehle G, Sava M, Deigendesch N, Battegay M, Infanti L, Holbro A, Bassetti S, Pargger H, Hirsch HH, Leuzinger K, Kaiser L, Vu D, Baur K, Massaro N, Busch MP, Simmons G, Stone M, Felgner PL, de Assis RR, Khan S, Tsai C, Robinson PV, Seftel D, Irsch J, Bagri A, Buser AS, Corash L |
Transfusion | 2022 |
Convalescent plasma and COVID‐19: Time for a second—second look?
Joyner MJ, Carter RE, Fairweather D, Wright RS |
Transfusion Medicine | 2022 |
Lack of efficacy of convalescent plasma in COVID‐19 patients with concomitant hematological malignancies: An Italian retrospective study
Lanza F, Monaco F, Ciceri F, Cairoli R, Sacchi MV, Guidetti A, Marchetti M, Massaia M, Arcaini L, Krampera M, Mohamed S, Gherlinzoni F, Mecucci C, Gentile M, Romano I, Venditti A, Ruggeri M, Ferrero D, Coviello E, Fabbri E, Corradini P, Passamonti F |
Hematological Oncology | 2022 |
Efficacy and Safety of COVID-19 Convalescent Plasma in Hospitalized Patients-An Open-Label Phase II Clinical Trial.
Grubovic Rastvorceva RM, Useini S, Stevanovic M, Demiri I, Petkovic E, Franchini M, Focosi D |
2022 | |
Cardiovascular Factors Associated with COVID-19 from an International Registry of Primarily Japanese Patients.
Matsumori A, Auda ME, Bruno KA, Shapiro KA, Kato T, Nakamura T, Hasegawa K, Saleh A, Abdelrazek S, Negm H, Karunawan NH, Cooper LT Jr, Fairweather D |
2022 | |
A Multicenter, Prospective, Observational, Cohort-Controlled Study of Clinical Outcomes Following Coronavirus Disease 2019 (COVID-19) Convalescent Plasma Therapy in Hospitalized Patients With COVID-19.
Chauhan L, Pattee J, Ford J, Thomas C, Lesteberg K, Richards E, Bernas CA, Loi M, Dumont L, Annen K, Berg M, Zirbes M, Knight V, Miller A, Jenkins TC, Bennett TD, Monkowski D, Boxer RS, Beckham JD |
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2022 |
Analysis of Convalescent Plasma Transfusion in Children Confirmed with COVID-19: A Systemic Review.
Casman C, Fitriani N, Gunawan D, Rohayati R |
2022 | |
The clinical outcomes of high neutralizing antibodies titer convalescent plasma therapy in early developed severe COVID-19 patients; a case-control study.
Nontawong N, Siripongboonsitti T, Tawinprai K, Boonpratoom M, Krailassiri N, Boonkhum C, Soonklang K, Poovorawan Y, Mahanonda N |
Annals of clinical microbiology and antimicrobials | 2022 |
Validation of Viral Inactivation Protocols for Therapeutic Blood Products against Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)
Belem WF, Liu CH, Hu YT, Burnouf T, Lin LT |
Viruses | 2022 |
Evaluation of a COVID-19 convalescent plasma program at a U.S. academic medical center
Root HB, Gilleskie M, Lu CH, Gilmore A, Evans M, Nelson BG, Johnson W, Gurney B, Kuruc J, Markmann AJ, Barzin AH, Wohl DA, Fischer WA, Park YA, Weiss S, Napravnik S, Baric R, de Silva AM, Lachiewicz AM, van Duin D, Margolis DM, Herce ME, Bartelt LA |
PloS one | 2022 |
Neutralizing and enhancing antibodies against SARS-CoV-2
Liu Y, Arase H |
Ensho Saisei | 2022 |
Impact of COVID-19 in solid organ transplant recipients
Danziger-Isakov L, Blumberg EA, Manuel O, Sester M |
American Journal of Transplantation | 2022 |
Effects of convalescent plasma infusion on the ADAMTS13-von Willebrand factor axis and endothelial integrity in patients with severe and critical COVID-19
Zhang Q, Ye Z, McGowan P, Jurief C, Ly A, Bignotti A, Yada N, Zheng XL |
Research and Practice in Thrombosis and Haemostasis | 2022 |
A pregnant woman with COVID-19 gives birth to premature triplets: A case report and literature review
Feng Z |
2022 | |
Early Treatment with Monoclonal Antibodies or Convalescent Plasma Reduces Mortality in Non-Vaccinated COVID-19 High-Risk Patients
Thümmler L, Lindemann M, Horn PA, Lenz V, Konik M, Gäckler A, Boss K, Theodoropoulos F, Besa V, Taube C, Brenner T, Witzke O, Krawczyk A, Rohn H |
Viruses | 2022 |
The Evolving Regulatory Landscape in Regenerative Medicine
Beetler DJ, Di Florio DN, Law EW, Groen CM, Windebank AJ, Peterson QP, Fairweather D |
Molecular Aspects of Medicine | 2022 |
'Convalescent Plasma'- An Effective Treatment Option to Prevent Emerging nCOVID-19- A Review.
Ashique S, Khatun T, Sahu G, Upadhyay A, Adhana A, Kumar S, Sandhu N, Kumar N |
Infectious disorders drug targets | 2022 |
An evaluation of the results of convalescent plasma therapy applied to pregnant women diagnosed as COVID-19-positive in a pandemic center: A prospective cohort study
EROL SA, TANAÇAN A, APAYDIN H, GÖNCÜ AYHAN Ş, OLUKLU D, UYAN HENDEM D, ÜNLÜ S, ERDEN A, MORALOĞLU TEKİN Ö, OMMA A, ATEŞ İ, KÜÇÜKŞAHİN O, ŞAHİN D |
2022 | |
A randomized controlled study of convalescent plasma for individuals hospitalized with COVID-19 pneumonia
Katharine J. Bar, Pamela A Shaw, Grace H Choi, Nicole Aqui, Andrew Fesnak, Jasper B. Yang, Haideliza Soto-Calderon, Lizette Grajales, Julie Starr, Michelle Andronov, Miranda Mastellone, Chigozie Amonu, Geoff Feret, Maureen DeMarshall, Marie Buchanan, Maria Caturla, James Gordon, Alan Wanicur, M. Alexandra Monroy, Felicity Mampe, Emily Lindemuth, Sigrid Gouma, Anne M Mullin, Holly Barilla, Anastasiya Pronina, Leah Irwin, Raeann Thomas, Risa A. Eichinger, Faye Demuth, Eline T. Luning Prak, Jose L. Pascual, William Short, Michal A. Elovitz, Jillian Baron, Nuala J Meyer, Kathleen O. Degnan, Ian Frank, Scott Hensley, Donald L. Siegel, Pablo Tebas |
Journal of Clinical Investigation | 2021 |
Treatment of Severe COVID-19 with Convalescent Plasma in Bronx, NYC
Hyun ah Yoon, Rachel Bartash, Inessa Gendlina, Johanna Rivera, Antonio Nakouzi, Robert H. Bortz III, Ariel S. Wirchnianski, Monika Paroder, Karen Fehn, Leana Serrano-Rahman, Rachelle Babb, Uzma N. Sarwar, Denise Haslwanter, Ethan Laudermilch, Catalina Florez, M. Eugenia Dieterle, Rohit K Jangra, J. Maximilian Fels, Karen Tong, Margarette C. Mariano, Olivia Vergnolle, George I. Georgiev, Natalia G. Herrera, Ryan J. Malonis, Jose A. Quiroz, Nicholas C. Morano, Gregory J. Krause, Joseph M. Sweeney, Kelsie Cowman, Stephanie A Allen, Jayabhargav Annam, Ariella Applebaum, Daniel Barboto, Ahmed Khokhar, Brianna J. Lally, Audrey Lee, Max Lee, Avinash Malaviya, Reise Sample, Xiuyi A Yang, Yang Li, Rafael E Ruiz, Raja Thota, Jason Barnhill, Doctor Y. Goldstein, Joan Uehlinger, Scott J. Garforth, Steven C. Almo, Jonathan R. Lai, Morayma Reyes Gil, Amy S. Fox, Kartik Chandran, Tao Wang, Johanna P Daily, Liise-anne Pirofski |
JCI Insight | 2021 |
Clinical and laboratory evaluation of patients with SARS-CoV-2 pneumonia treated with high-titer convalescent plasma
Michele Donato, Steven Park, Melissa Baker, Robert Korngold, Alison Morawski, Xue Geng, Ming Tan, Andrew Ip, Stuart Goldberg, Scott D. Rowley, Kar F Chow, Emily Brown, Joshua Zenreich, Phyllis McKiernan, Kathryn Buttner, Anna Ullrich, Laura Long, Rena Feinman, Andrea Ricourt, Marlo Kemp, Mariefel Vendivil, Hyung C. Suh, Bindu Balani, Cristina Cicogna, Rani Sebti, Abdulla Al-Khan, Steven J. Sperber, Samit Desai, Stacey L. Fanning, Danit Arad, Ronaldo C. Go, Elizabeth Tam, Keith Rose, Sean Sadikot, David S Siegel, Martin Gutierrez, Tatyana Feldman, Andre Goy, Andrew Pecora, Noa Biran, Lori A. Leslie, Alfred Gillio, Sarah Timmapuri, Michele S. Boonstra, Sam Singer, Sukhdeep Kaur, Ernest Richards, David S Perlin |
JCI Insight | 2021 |
Neutralization of SARS-CoV-2 with IgG from COVID-19-convalescent plasma
K Maeda, N Higashi-Kuwata, N Kinoshita, S Kutsuna, K Tsuchiya, S Hattori, K Matsuda, Y Takamatsu, H Gatanaga, S Oka, H Sugiyama, N Ohmagari, H Mitsuya |
Scientific Reports | 2021 |
Potent prophylactic and therapeutic efficacy of recombinant human ACE2-Fc against SARS-CoV-2 infection in vivo
Z Zhang, E Zeng, L Zhang, W Wang, Y Jin, J Sun, S Huang, W Yin, J Dai, Z Zhuang, Z Chen, J Sun, A Zhu, F Li, W Cao, X Li, Y Shi, M Gan, S Zhang, P Wei, J Huang, N Zhong, G Zhong, J Zhao, Y Wang, W Shao, J Zhao |
Cell Discovery | 2021 |
Convalescent plasma is of limited clinical benefit in critically ill patients with coronavirus disease-2019: a cohort study
L Huang, C Zhang, X Zhou, Z Zhao, W Wang, W Leng, X Su, Q Lian |
Journal of Translational Medicine | 2021 |
Nasal Administration of Anti-CD3 Monoclonal Antibody (Foralumab) Reduces Lung Inflammation and Blood Inflammatory Biomarkers in Mild to Moderate COVID-19 Patients: A Pilot Study
TG Moreira, KT Matos, GS Paula, TM Santana, RG Mata, FC Pansera, AS Cortina, MG Spinola, GD Keppeke, J Jacob, V Palejwala, K Chen, S Izzy, BC Healey, RM Rezende, RA Dedivitis, K Shailubhai, HL Weiner |
Frontiers in immunology | 2021 |
Impact of serological and PCR testing requirements on the selection of COVID ‐19 convalescent plasma donors
JA Carter, AT Freedenberg, JL Romeiser, LR Talbot, NJ Browne, ME Cosgrove, ME Shevik, LM Generale, MG Rago, GA Caravella, T Ahmed, LJ Mamone, E BennettGuerrero |
Transfusion | 2021 |
COVID-19 convalescent plasma composition and immunological effects in severe patients
Y Acosta-Ampudia, DM Monsalve, M Rojas, Y Rodríguez, JE Gallo, JC Salazar-Uribe, MJ Santander, MP Cala, W Zapata, MI Zapata, R Manrique, JM Pardo-Oviedo, B Camacho, C Ramírez-Santana, JM Anaya |
Journal of Autoimmunity | 2021 |
Decay of Fc-dependent antibody functions after mild to moderate COVID-19
WS Lee, KJ Selva, SK Davis, BD Wines, A Reynaldi, R Esterbauer, HG Kelly, ER Haycroft, HX Tan, JA Juno, AK Wheatley, PM Hogarth, D Cromer, MP Davenport, AW Chung, SJ Kent |
Reproduction | 2021 |
Fc-engineered antibody therapeutics with improved efficacy against COVID-19
Jeffrey Ravetch, Rachel Yamin, Andrew Jones, Hans-Heinrich Hoffmann, Kevin Kao, Rebecca Francis, Timothy Sheahan, Ralph Baric, Charles Rice, Stylianos Bournazos |
Research square | 2021 |
Convalescent Plasma for Infectious Diseases: Historical Framework and Use in COVID-19
JG Ripoll, N van Helmond, JW Senefeld, CC Wiggins, SA Klassen, SE Baker, KF Larson, BM Murphy, KJ Andersen, SK Ford, A Casadevall, MJ Joyner |
Clinical Microbiology Newsletter | 2021 |
SARS-CoV-2: vaccines in the pandemic era
DD Li, QH Li |
Military Medical Research | 2021 |
A look-back at convalescent plasma to treat COVID-19
O Garraud, K Lacombe, P Tiberghien |
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis | 2021 |
A review of COVID-19 convalescent plasma use in COVID-19 with focus on proof of efficacy
PK Devarasetti, L Rajasekhar, R Baisya, KS Sreejitha, YK Vardhan |
Immunologic Research | 2021 |
Use of convalescent serum reduces severity of COVID-19 in nonhuman primates
RW Cross, AN Prasad, V Borisevich, C Woolsey, KN Agans, DJ Deer, NS Dobias, JB Geisbert, KA Fenton, TW Geisbert |
Cell Reports | 2021 |
Integrative overview of antibodies against SARS-CoV-2 and their possible applications in COVID-19 prophylaxis and treatment
NA Valdez-Cruz, E García-Hernández, C Espitia, L Cobos-Marín, C Altamirano, CG Bando-Campos, LF Cofas-Vargas, EW Coronado-Aceves, RA González-Hernández, P Hernández-Peralta, D Juárez-López, PA Ortega-Portilla, S Restrepo-Pineda, P Zelada-Cordero, MA Trujillo-Roldán |
Microbial cell factories | 2021 |
Convalescent plasma for adults with acute COVID-19 respiratory illness (CONCOR-1): study protocol for an international, multicentre, randomized, open-label trial
P Bégin, J Callum, NM Heddle, R Cook, MP Zeller, A Tinmouth, DA Fergusson, MM Cushing, MJ Glesby, M Chassé, DV Devine, N Robitalle, R Bazin, N Shehata, A Finzi, A McGeer, DC Scales, L Schwartz, AF Turgeon, R Zarychanski, N Daneman, R Carl, L Amorim, C Gabe, M Ellis, BS Sachais, KC Loftsgard, E Jamula, J Carruthers, J Duncan, K Lucier, N Li, Y Liu, C Armali, A Kron, D Modi, MC Auclair, S Cerro, M Avram, DM Arnold |
Trials | 2021 |
Convalescent plasma therapy in B-cell-depleted and B-cell sufficient patients with life-threatening COVID-19 – A case series
J Erber, JR Wiessner, C Huberle, J Schneider, H Mijočević, D von Bomhard, P Luppa, RM Schmid, S Rasch, T Lahmer |
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis | 2021 |
Promising Immunotherapies against COVID‐19
H Guo, L Zhou, Z Ma, Z Tian, F Zhou |
2021 | |
Recent advances in antibody‐based immunotherapy strategies for COVID‐19
A Esmaeilzadeh, S Rostami, PM Yeganeh, S Tahmasebi, M Ahmadi |
Journal of Cellular Biochemistry | 2021 |
Functional convalescent plasma antibodies and pre-infusion titers shape the early severe COVID-19 immune response
JD Herman, C Wang, C Loos, H Yoon, J Rivera, ME Dieterle, D Haslwanter, RK Jangra, RH Bortz, KJ Bar, B Julg, K Chandran, D Lauffenburger, L Pirofski, G Alter |
Nature Communications | 2021 |
The Journal of Clinical Investigation in the time of COVID-19
A Casadevall, S Jackson, GL Semenza, GF Tomaselli, RS Ahima |
Journal of Clinical Investigation | 2021 |
Convalescent Plasma Therapy for COVID-19: A Graphical Mosaic of the Worldwide Evidence
SA Klassen, JW Senefeld, KA Senese, PW Johnson, CC Wiggins, SE Baker, N van Helmond, KA Bruno, L Pirofski, S Shoham, BJ Grossman, JP Henderson, RS Wright, DL Fairweather, NS Paneth, RE Carter, A Casadevall, MJ Joyner |
Frontiers in Medicine | 2021 |
The Effect of Convalescent Plasma Therapy on Mortality Among Patients With COVID-19: Systematic Review and Meta-analysis
SA Klassen, JW Senefeld, PW Johnson, RE Carter, CC Wiggins, S Shoham, BJ Grossman, JP Henderson, J Musser, E Salazar, WR Hartman, NM Bouvier, ST Liu, L Pirofski, SE Baker, N van Helmond, RS Wright, DL Fairweather, KA Bruno, Z Wang, NS Paneth, A Casadevall, MJ Joyner |
Mayo Clinic Proceedings | 2021 |
Are We Forgetting About IgA? A Re‐examination of Coronavirus Disease 2019 Convalescent Plasma
H Verkerke, BJ Saeedi, D Boyer, JW Allen, J Owens, S Shin, M Horwath, K Patel, A Paul, SC Wu, J Wang, A Ho, CL Maier, PE Zerra, S Chonat, CM Arthur, JD Roback, AS Neish, C Lough, CD Josephson, SR Stowell |
Transfusion | 2021 |
Convalescent Plasma for the Prevention and Treatment of COVID-19: A Systematic Review and Quantitative Analysis
HT Peng, SG Rhind, A Beckett |
2021 | |
Intravenous Immunoglobulins at the Crossroad of Autoimmunity and Viral Infections
C Perricone, P Triggianese, R Bursi, G Cafaro, E Bartoloni, MS Chimenti, R Gerli, R Perricone |
Microorganisms | 2021 |
Elevated cytokines and chemokines in peripheral blood of patients with SARS-CoV-2 pneumonia treated with high-titer convalescent plasma
SL Fanning, R Korngold, Z Yang, K Goldgirsh, S Park, J Zenreich, M Baker, P McKiernan, M Tan, B Zhang, ML Donato, DS Perlin, SR Shih |
PLoS pathogens | 2021 |
Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review
V Piechotta, C Iannizzi, KL Chai, SJ Valk, C Kimber, E Dorando, I Monsef, EM Wood, AA Lamikanra, DJ Roberts, Z McQuilten, C So-Osman, LJ Estcourt, N Skoetz |
Cochrane Database of Systematic Reviews | 2021 |
Regulatory challenges of convalescent plasma collection during the evolving stages of COVID ‐19 pandemic in the United States
S Hassan, KA West, K ConryCantilena, VD Giorgi |
Transfusion | 2021 |
Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19
MJ Joyner, RE Carter, JW Senefeld, SA Klassen, JR Mills, PW Johnson, ES Theel, CC Wiggins, KA Bruno, AM Klompas, ER Lesser, KL Kunze, MA Sexton, JC Soto, SE Baker, JR Shepherd, N van Helmond, NC Verdun, P Marks, CM van Buskirk, JL Winters, JR Stubbs, RF Rea, DO Hodge, V Herasevich, ER Whelan, AJ Clayburn, KF Larson, JG Ripoll, KJ Andersen, MR Buras, MN Vogt, JJ Dennis, RJ Regimbal, PR Bauer, JE Blair, NS Paneth, DL Fairweather, RS Wright, A Casadevall |
New England Journal of Medicine | 2021 |
Comparative Performance of Five Commercially Available Serologic Assays To Detect Antibodies to SARS-CoV-2 and Identify Individuals with High Neutralizing Titers
EU Patel, EM Bloch, W Clarke, YH Hsieh, D Boon, Y Eby, RE Fernandez, OR Baker, M Keruly, CS Kirby, E Klock, K Littlefield, J Miller, HA Schmidt, P Sullivan, E Piwowar-Manning, R Shrestha, AD Redd, RE Rothman, D Sullivan, S Shoham, A Casadevall, TC Quinn, A Pekosz, AA Tobian, O Laeyendecker, MJ Loeffelholz |
Journal of clinical microbiology | 2021 |
COVID ‐19 convalescent plasma: Interim recommendations from the AABB
CS Cohn, L Estcourt, BJ Grossman, MB Pagano, ES Allen, EM Bloch, A Casadevall, DV Devine, NM Dunbar, F Foroutan, TJ Gniadek, R Goel, J Gorlin, MJ Joyner, RA Metcalf, JS Raval, TW Rice, BH Shaz, RR Vassallo, JL Winters, G Beaudoin, AA Tobian |
Transfusion | 2021 |
Convalescent Plasma Therapy in Critically Ill COVID-19 Patients: An Open Label Trial
F Khamis, ZA Arimi, HA Naamani, MA Bahrani, N Pandak, ZA Bolushi, SS Deenadayalan, AA Lawati, IA Salmi, I Al-Zakwani |
Oman Medical Journal | 2021 |
A Narrative Review of a Pulmonary Aerosolized Formulation or a Nasal Drop Using Sera Containing Neutralizing Antibodies Collected from COVID-19-Recovered Patients as a Probable Therapy for COVID-19
Nishat Fatima, Vichitra Kaushik, Amjad Ayoub |
Iranian journal of medical sciences | 2021 |
Convalescent plasma therapy as a conventional trick for treating COVID-19: a systematic review and meta-analysis study
M Keikha, M Karbalaei |
New Microbes and New Infections | 2021 |
Preparedness and activities of the anti-SARS-CoV-2 convalescent plasma bank in the Veneto region (Italy): An organizational model for future emergencies
GD Silvestro, G Gandini, F Fiorin, P Marson, E Barbone, A Frigato, G Gessoni, A Veronesi, M Pacenti, M Castelli, M Rinaldi, M Rizzi, F Stefani, G Roveroni |
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis | 2021 |
Use of convalescent plasma for COVID-19 in India: A review & practical guidelines
NS Khaire, N Jindal, LN Yaddanapudi, S Sachdev, R Hans, N Sachdeva, MP Singh, A Agarwal, A Mukherjee, G Kumar, RR Sharma, V Suri, GD Puri, P Malhotra |
The Indian journal of medical research | 2021 |
Convalescent blood plasma (CBP) donated by recovered COVID-19 patients – A comment
T Lung, B Sakem, M Risch, U Nydegger |
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis | 2021 |
Digital Health Surveillance Strategies for Management of Coronavirus Disease 2019
T Jose, DO Warner, JC OHoro, SG Peters, R Chaudhry, MJ Binnicker, CD Burger |
2021 | |
Safety and Efficacy of Convalescent Plasma for Severe COVID-19: Interim Report of a Multicenter Phase II Study from Saudi Arabia
N AlShehry, SZ Zaidi, A AlAskar, AA Odayani, JM Alotaibi, A AlSagheir, A Al-Eyadhy, S Balelah, A Salam, AR Zaidi, D Alawami, MS Alshahrani, N AlMozain, YM Abulhamayel, RA Qunfoidi, M Alfaraj, N Qushmaq, R Alansari, A Dayel, G Elgohary, AA Bahrani, AA Abdelhameed, HA AlZahrani, H Alturkistani, N AlShehry, MA Albalawi, I Elalfy, H Alhumaidan, H Al-Hashmi |
2021 | |
Effect of convalescent blood products for patients with severe acute respiratory infections of viral etiology: A systematic review and meta-analysis
S Shao, Y Wang, H Kang, Z Tong |
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2021 |
Two patients with rituximab associated low gammaglobulin levels and relapsed covid-19 infections treated with convalescent plasma
IO Vélez, JI Bermejo, JE Pérez, LI Aguayo, MD Ruiz, JA García-Erce |
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis | 2021 |
Quantifying Absolute Neutralization Titers against SARS-CoV-2 by a Standardized Virus Neutralization Assay Allows for Cross-Cohort Comparisons of COVID-19 Sera
KY Oguntuyo, CS Stevens, CT Hung, S Ikegame, JA Acklin, SS Kowdle, JC Carmichael, HP Chiu, KD Azarm, GD Haas, F Amanat, J Klingler, I Baine, S Arinsburg, JC Bandres, MN Siddiquey, RM Schilke, MD Woolard, H Zhang, AJ Duty, TA Kraus, TM Moran, D Tortorella, JK Lim, AV Gamarnik, CE Hioe, S Zolla-Pazner, SS Ivanov, JP Kamil, F Krammer, B Lee, K Subbarao |
mBio | 2021 |
SARS-CoV-2 infection: molecular mechanisms of severe outcomes to suggest therapeutics
N Hartog, W Faber, A Frisch, J Bauss, CP Bupp, S Rajasekaran, JW Prokop |
Expert Review of Proteomics | 2021 |
Passive Immunity Should and Will Work for COVID-19 for Some Patients:
N Cimolai |
2021 | |
Perspectives for immune plasma treatment of COVID-19
B SAYINALP, OE ÇINAR, İC HAZNEDAROĞLU |
2021 | |
The Principles of Antibody Therapy for Infectious Diseases with Relevance for COVID-19
A Casadevall, L Pirofski, MJ Joyner, DA Garsin |
mBio | 2021 |
Convalescent plasma use in the USA was inversely correlated with COVID-19 mortality
A Casadevall, Q Dragotakes, PW Johnson, JW Senefeld, SA Klassen, RS Wright, MJ Joyner, N Paneth, RE Carter |
eLife | 2021 |
The Effectiveness of Convalescent Plasma for the Treatment of Novel Corona Virus Disease 2019: A Systematic Review and Meta-Analysis
H Cao, L Ming, L Chen, X Zhu, Y Shi |
Frontiers in Medicine | 2021 |
Immunotherapy Summary for Cytokine Storm in COVID-19
Y Li, W Zhao, J Liu, Z Chen, Q Lv, Z Zhang |
Frontiers in pharmacology | 2021 |
Administration of high titer convalescent anti-SARS-CoV-2 plasma: From donor selection to monitoring recipient outcomes
RP Mendoza, W Fyke, D Daniel, E Gabutan, B Das, H Bajaj, M Easy, A Vasileva, R Colbourn, M Alawad, A Dehghani, B Lin, D Emechebe, P Patel, A Jabbar, DB Nikolov, D Giovaniello, S Kang, L Tatem, K Bromberg, M Augenbraun, P Premsrirut, J Libien, AJ Norin |
Human Immunology | 2021 |
Repositioned Drugs for COVID-19—the Impact on Multiple Organs
C Chan, ST Foster, KG Chan, MJ Cacace, SL Ladd, CT Sandum, PT Wright, B Volmert, W Yang, A Aguirre, W Li, NT Wright |
2021 | |
Further comments on the role of ACE ‐2 positive macrophages in human lung
W Hu, X Song, H Yu, L Zhao, Y Zhao, Y Zhao |
Cytometry Part A | 2021 |
Dynamics of antibodies to SARS‐CoV‐2 in convalescent plasma donors
M Steenhuis, G Mierlo, NI Derksen, PO Heer, S Kruithof, FL Loeff, LC Berkhout, F Linty, C Reusken, J Reimerink, B Hogema, H Zaaijer, L Watering, F Swaneveld, MJ Gils, BJ Bosch, SM Ham, A Brinke, G Vidarsson, EC Schoot, T Rispens |
IBMS BoneKEy | 2021 |
Assessment of anti‐SARS‐CoV‐2 antibodies level in convalescents plasma
A Skorek, A JaźwińskaCuryłło, A Romanowicz, K Kwaśniewski, W Narożny, D Tretiakow |
Journal of Medical Virology | 2021 |
Treating the endotheliopathy of SARS‐CoV ‐2 infection with plasma: Lessons learned from optimized trauma resuscitation with blood products
S Pati, E Fennern, JB Holcomb, M Barry, A Trivedi, AP Cap, MJ Martin, C Wade, R Kozar, JC Cardenas, JF Rappold, R Spiegel, MA Schreiber |
Transfusion | 2021 |
Hospital-Based Donor Recruitment and Predonation Serologic Testing for COVID-19 Convalescent Plasma
J Balcerek, E Trejo, K Levine, P Couey, ZV Kornberg, C Rogine, C Young, PJ Li, BR Shy, JE Taylor, S Bakhtary, T Friedlander, KL Lynch, C Bern, JH Esensten |
American Journal of Clinical Pathology | 2021 |
Aging in COVID-19: Vulnerability, immunity and intervention
Y Chen, SL Klein, BT Garibaldi, H Li, C Wu, NM Osevala, T Li, JB Margolick, G Pawelec, SX Leng |
Ageing Research Reviews | 2021 |
Immunological effects of convalescent plasma therapy for coronavirus: a scoping review
B Esmaeili, S Esmaeili, Z Pourpak |
BMC Infectious Diseases | 2021 |
Convalescence plasma treatment of COVID-19: results from a prematurely terminated randomized controlled open-label study in Southern Sweden
K Holm, MN Lundgren, J Kjeldsen-Kragh, O Ljungquist, B Böttiger, C Wikén, J Öberg, N Fernström, E Rosendal, AK Överby, JW Byström, M Forsell, M Landin-Olsson, M Rasmussen |
BMC Research Notes | 2021 |
Therapeutic Use of Convalescent Plasma in COVID-19 Infected Patients with Concomitant Hematological Disorders:
F Lanza, V Agostini, F Monaco, F Passamonti, J Seghatchian |
2021 | |
The importance of determining the amount of ‘therapeutic units’ before using convalescent plasma
YR Vieira, J Fernandes, MA Pinto, ER de Lemos, A Guterres |
Future Virology | 2021 |
Therapeutic antibodies under development for SARS‐CoV‐2
Z Ma, MM Zhu, S Zhang, K Qian, C Wang, W Fu, C Lei, S Hu |
2021 | |
Active surveillance of serious adverse events following transfusion of COVID ‐19 convalescent plasma
E Swenson, LK Wong, P Jhaveri, Y Weng, S Kappagoda, S Pandey, A Pritchard, A Rogers, S Ruoss, A Subramanian, H Shan, M Hollenhorst |
Transfusion | 2021 |
SARS-CoV-2: Current trends in emerging variants, pathogenesis, immune responses, potential therapeutic, and vaccine development strategies
A Salimi-Jeda, S Abbassi, A Mousavizadeh, M Esghaie, F Bokharaei-Salim, F Jeddi, M Shafaati, A Abdoli |
International Immunopharmacology | 2021 |
Convalescent plasma for SARS-CoV-2 infection: Win or Learn
E Contreras-Barbeta, A Millan, J Rello |
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology | 2021 |
Experience of Treating COVID-19 With Remdesivir and Convalescent Plasma in a Resource-Limited Setting: A Prospective, Observational Study
J Koirala, P Gyanwali, RB Gerzoff, S Bhattarai, B Nepal, R Manandhar, R Jha, S Sharma, YR Sharma, A Bastola, H Murphy, S Acharya, P Adhikari, M Rajkarnikari, KM Vaidya, CL Panthi, B Bista, G Giri, S Aryal, S Pant, A Pokharel, S Karki, S Basnet, B Koirala, M Dhimal, RK Jha, A Shrestha, A Dhungana, S Shrestha, S Pandey, S Shakya, PS Ranjit, S Dhungel, D Bhattarai, S Gautam, P Poudel, K Sapkota, KJ Shah, RK Mandal, R Pandey, S Prajapati, A Hussain, S Gupta, R Chhetri, K Pokharel, K Thapa, S Adhikari, GP Deo, B Gauli, P Ghimire, B Regmi, RB Gurung, R Shrestha, D Tamrakar, S Khanal, U Acharya, S Sapkota, R Shrestha, MJ Sijapati, S Koirala, S Bajracharya, D Sigdel, DP Acharya, S Chhetri, P Acharya, HP Panthi, A Dhungana, AR Karki, RK Singh, UN Singh, R Tiwari, A Hussain, R Shah, PA Ansari, D Aryal, SK Shrestha, K Koirala, KK KC, BP Acharya, S BK, S Pandey, SK Gupta, D Shakya, Y Sapkota, A Adhikari, B Koirala, B Karki, YR Sharma, BK Pandey, BS Lamichhane, S Shrestha, SB Kamar, A Chaudhary, J Joshi, K Sherpa, R Manandhar, C Pant, R Joshi, A Bastola, BS Chalise, SK Das, PS Shrestha |
Open Forum Infectious Diseases | 2021 |
Comparing antiviral strategies against COVID-19 via multiscale within-host modelling
F Fatehi, RJ Bingham, EC Dykeman, PG Stockley, R Twarock |
Royal Society Open Science | 2021 |
Effectiveness of Convalescent Plasma Therapy in Severe or Critically Ill COVID-19 Patients: A Retrospective Cohort Study
YS Cho, YJ Sohn, JH Hyun, YJ Baek, MH Kim, JH Kim, JY Ahn, SJ Jeong, NS Ku, JS Yeom, MY Ahn, DH Oh, JP Choi, SY Kim, KH Lee, YG Song, JY Choi |
Yonsei Medical Journal | 2021 |
Current advances in transfusion medicine 2020: A critical review of selected topics by the AABB Clinical Transfusion Medicine Committee
ES Allen, CS Cohn, S Bakhtary, NM Dunbar, T Gniadek, CK Hopkins, J Jacobson, PM Lokhandwala, RA Metcalf, C Murphy, MT Prochaska, JS Raval, H Shan, EK Storch, MB Pagano |
Transfusion | 2021 |
Multidimensional Evaluation of All-Cause Mortality Risk and Survival Analysis for Hospitalized Patients with COVID-19
J Li, H Luo, G Deng, J Chang, X Qiu, C Liu, B Qin |
International journal of medical sciences | 2021 |
COVID-19 challenges and its therapeutics
SU Rehman, SU Rehman, HH Yoo |
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie | 2021 |
Inhibition of SARS-CoV-2 pseudovirus invasion by ACE2 protecting and Spike neutralizing peptides: An alternative approach to COVID19 prevention and therapy
J Chen, S Li, Z Lei, Q Tang, L Mo, X Zhao, F Xie, D Zi, J Tan |
International journal of biological sciences | 2021 |
Clinical Management of Adult Patients with COVID-19 Outside Intensive Care Units: Guidelines from the Italian Society of Anti-Infective Therapy (SITA) and the Italian Society of Pulmonology (SIP)
M Bassetti, DR Giacobbe, P Bruzzi, E Barisione, S Centanni, N Castaldo, S Corcione, FG Rosa, FD Marco, A Gori, A Gramegna, G Granata, A Gratarola, AE Maraolo, M Mikulska, A Lombardi, F Pea, N Petrosillo, D Radovanovic, P Santus, A Signori, E Sozio, E Tagliabue, C Tascini, C Vancheri, A Vena, P Viale, F Blasi, M Bassetti, DR Giacobbe, P Bruzzi, E Barisione, S Centanni, N Castaldo, S Corcione, FG Rosa, FD Marco, A Gori, A Gramegna, G Granata, A Gratarola, AE Maraolo, M Mikulska, A Lombardi, F Pea, N Petrosillo, D Radovanovic, P Santus, A Signori, E Sozio, E Tagliabue, C Tascini, C Vancheri, A Vena, P Viale, F Blasi |
Infectious Diseases and Therapy | 2021 |
HLA B53 is associated with a poor outcome in black COVID-19 patients
AJ Norin, R Mendoza, M Augenbraun, B Das |
Human Immunology | 2021 |
Making trials part of good clinical care: lessons from the RECOVERY trial
G Pessoa-Amorim, M Campbell, L Fletcher, P Horby, M Landray, M Mafham, R Haynes |
2021 | |
The safety of COVID ‐19 convalescent plasma donation: A multi‐institutional donor hemovigilance study
JH Cho, S Rajbhandary, NL Buren, MK Fung, M AlGhafry, JL Fridey, BA Dy, A Ziman, GB Schreiber, RR Gammon, R Reik, JR Stubbs, CM Buskirk, H Kamel, MJ Townsend, MP Zeller, JL Gottschall |
Transfusion | 2021 |
Dramatic Response to Convalescent Hyperimmune Plasma in Association With an Extended Course of Remdesivir in 4 B Cell–Depleted Non-Hodgkin Lymphoma Patients With SARS-Cov-2 Pneumonia After Rituximab Therapy
A Furlan, G Forner, L Cipriani, E Vian, R Rigoli, F Gherlinzoni, P Scotton |
Clinical Lymphoma, Myeloma & Leukemia | 2021 |
COVID ‐19 convalescent plasma cohort study: Evaluation of the association between both donor and recipient neutralizing antibody titers and patient outcomes
AP Yokoyama, S Wendel, C BonetBub, RM Fachini, AP Dametto, F Blumm, VF Dutra, GT Candelaria, AM Sakashita, RR Machado, R FontãoWendel, N Hamerschlak, R Achkar, MS Assunção, P Scuracchio, V Nudelman, L Pastore, JR Pinho, MD Ben, RK Filho, AR Marra, MT Amano, EG Kallás, AS Helito, CR Carvalho, DB Araujo, EL Durigon, AA Camargo, LV Rizzo, LF Reis, JM Kutner |
Transfusion | 2021 |
COVID-19 convalescent plasma therapy for immunodeficient patients–weighing up risks and benefits
T Vuk, A Hećimović, I Jukić, S Ravlić, T Kurtović, D Rnjak, B Halassy |
Transfusion Clinique et Biologique | 2021 |
Convalescent plasma as a treatment modality for Coronavirus Disease 2019 in Indonesia: A case reports
A Thabrani, WS Hadi, JA Thobari, Z Novianti, Kurniyanto, I Juliana, A Suharto, AN Danaswari, I Septiani, S Rhatomy |
Annals of Medicine and Surgery | 2021 |
Effectiveness of convalescent plasma therapy in a patient with severe COVID-19-associated acute kidney injury
ZZ Brener, A Brenner |
Clinical Nephrology – Case Studies | 2021 |
Necrotising myopathy and concurrent thyroiditis in a patient with COVID-19 infection
C Reggio, A Paudel, CS Specht, AA Donato |
BMJ case reports | 2021 |
Convalescent Plasma Efficacy in Life-Threatening COVID-19 Patients Admitted to the ICU: A Retrospective Cohort Study
M Abuzakouk, K Saleh, M Algora, A Nusair, J Alameri, F Alshehhi, S Alkhaja, M Badr, K Abdallah, BD Oliveira, A Nadeem, Y Varghese, D Munde, S Salam, B Abduljawad, H Elkambergy, A Wahla, A Taha, J Dibu, A Bayrlee, F Hamed, L AbdelWareth, N Rahman, J Guzman, J Mallat |
Journal of Clinical Medicine | 2021 |
Position paper on the use of COVID-19 convalescent plasma: an update
Daniele Prati, Francesco Fiorin, Pierluigi Berti, Giustina De Silvestro, Patrizia Accorsi, Angelo Ostuni, |
Blood transfusion = Trasfusione del sangue | 2021 |
Effects of potent neutralizing antibodies from convalescent plasma in patients hospitalized for severe SARS-CoV-2 infection
A Gharbharan, CC Jordans, C GeurtsvanKessel, JG den Hollander, F Karim, FP Mollema, JE Schukken, A Dofferhoff, I Ludwig, A Koster, RJ Hassing, JC Bos, GR van Pottelberge, IN Vlasveld, HS Ammerlaan, EM van Leeuwen Segarceanu, J Miedema, M van der Eerden, TJ Schrama, G Papageorgiou, P te Boekhorst, FH Swaneveld, YM Mueller, MW Schreurs, JJ van Kampen, B Rockx, NM Okba, PD Katsikis, MP Koopmans, BL Haagmans, C Rokx, BJ Rijnders |
Nature Communications | 2021 |
Randomized controlled trial of convalescent plasma therapy against standard therapy in patients with severe COVID-19 disease
M AlQahtani, A Abdulrahman, A Almadani, SY Alali, AM Zamrooni, AH Hejab, RM Conroy, P Wasif, S Otoom, SL Atkin, M Abduljalil |
Scientific Reports | 2021 |
What we have learned from the COVID-19 pandemic: Time to think outside the box, maybe far outside
WC Lambert, A Alhatem, MW Lambert, RA Schwartz |
Clinics in Dermatology | 2021 |
No Evidence for Human Monocyte-Derived Macrophage Infection and Antibody-Mediated Enhancement of SARS-CoV-2 Infection
O García-Nicolás, P Vkovski, F Zettl, G Zimmer, V Thiel, A Summerfield |
Frontiers in Cellular and Infection Microbiology | 2021 |
Convalescent plasma therapy - a silver lining for COVID-19 management?
S Saha, S Kadam |
2021 | |
Convalescent plasma therapy in COVID-19 critically ill patients during advanced phases of clinical trials and their preliminary results
FA de Oliveira, MP Nucci, GN de Albuquerque Rego, A da Hora Alves, LC Marti, LP Nucci, JB Mamani, LF Gamarra |
Einstein (São Paulo) | 2021 |
Suggested guidelines for convalescent plasma therapy for the treatment of COVID-19
GC Santis, A Mendrone, D Langhi, DT Covas, A Fabron, AJ Cortez, CL Dinardo, EM Ubiali, JF Marques, JO Bordin, MA Rugani |
2021 | |
Evaluation of the safety and efficacy of XAV-19 in patients with COVID-19-induced moderate pneumonia: study protocol for a randomized, double-blinded, placebo-controlled phase 2 (2a and 2b) trial
B Gaborit, B Vanhove, MA Vibet, AL Thuaut, K Lacombe, V Dubee, F Ader, V Ferre, E Vicaut, J Orain, ML Bras, A Omnes, L Berly, A Jobert, PM Houssine, K Botturi, R Josien, L Flet, N Degauque, S Brouard, O Duvaux, A Poinas, F Raffi |
Trials | 2021 |
Efficacy and Safety of Convalescent Plasma for COVID-19: A Systematic Review and Meta-analysis
M Prasad, T Seth, A Elavarasi |
Indian Journal of Hematology and Blood Transfusion | 2021 |
Passive Immunity Trial for Our Nation (PassITON): study protocol for a randomized placebo-control clinical trial evaluating COVID-19 convalescent plasma in hospitalized adults
WH Self, TG Stewart, AP Wheeler, WE Atrouni, AJ Bistran-Hall, JD Casey, VD Cataldo, JD Chappell, CS Cohn, JB Collins, MR Denison, M de Wit, SL Dixon, A Duggal, TL Edwards, MJ Fontaine, AA Ginde, MS Harkins, T Harrington, ES Harris, D Hoda, TS Ipe, SJ Jaiswal, NJ Johnson, AE Jones, M Laguio-Vila, CJ Lindsell, J Mallada, MJ Mammen, RA Metcalf, EA Middleton, S Mucha, HR ONeal, SR Pannu, JM Pulley, X Qiao, JS Raval, JP Rhoads, H Schrager, C Shanholtz, NI Shapiro, SJ Schrantz, I Thomsen, KK Vermillion, GR Bernard, TW Rice |
Trials | 2021 |
Establishment of a well-characterized SARS-CoV-2 lentiviral pseudovirus neutralization assay using 293T cells with stable expression of ACE2 and TMPRSS2
SN Neerukonda, R Vassell, R Herrup, S Liu, T Wang, K Takeda, Y Yang, TL Lin, W Wang, CD Weiss, NJ Mantis |
PloS one | 2021 |
SARS‐CoV‐2 and pediatric solid organ transplantation: Current knowns and unknowns
AG LHuillier, L DanzigerIsakov, A Chaudhuri, M Green, MG Michaels, K PosfayBarbe, D van der Linden, A Verma, M McCulloch, MI Ardura |
Pediatric Transplantation | 2021 |
Passive Immunity Trial for Our Nation (PassITON): study protocol for a randomized placebo-control clinical trial evaluating COVID-19 convalescent plasma in hospitalized adults
Wesley H Self, Thomas G Stewart, Allison P Wheeler, Wissam El Atrouni, Amanda J Bistran-Hall, Jonathan D Casey, Vince D Cataldo, James D Chappell, Claudia S Cohn, Jessica B Collins, Mark R Denison, Maijolein de Wit, Sheri L Dixon, Abhijit Duggal, Terri L Edwards, Magali J Fontaine, Adit A Ginde, Michelle S Harkins, Thelma Harrington, Estelle S Harris, Daanish Hoda, Tina S Ipe, Stuti J Jaiswal, Nicholas J Johnson, Alan E Jones, Maryrose Laguio-Vila, Christopher J Lindsell, Jason Mallada, Manoj J Mammen, Ryan A Metcalf, Elizabeth A Middleton, Simon Mucha, Hollis R O'Neal, Sonal R Pannu, Jill M Pulley, Xian Qiao, Jay S Raval, Jillian P Rhoads, Harry Schrager, Carl Shanholtz, Nathan I Shapiro, Stephen J Schrantz, Isaac Thomsen, Krista K Vermillion, Gordon R Bernard, Todd W Rice |
Research square | 2021 |
Modalities and Mechanisms of Treatment for Coronavirus Disease 2019
Z Zuo, T Wu, L Pan, C Zuo, Y Hu, X Luo, L Jiang, Z Xia, X Xiao, J Liu, M Ye, M Deng |
Frontiers in pharmacology | 2021 |
Therapeutic Strategies in the Management of COVID-19
RR Naik, AK Shakya |
Frontiers in Molecular Biosciences | 2021 |
Convalescent plasma treatment is associated with lower mortality and better outcomes in high-risk COVID-19 patients – propensity-score matched case-control study
A Tworek, K Jaroń, B Uszyńska-Kałuża, A Rydzewski, R Gil, A Deptała, E Franek, R Wójtowicz, K Życińska, I Walecka, M Cicha, W Wierzba, A Zaczyński, ZJ Król, G Rydzewska |
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2021 |
Matched Cohort Study of Convalescent COVID-19 Plasma Treatment in Severely or Life Threateningly Ill COVID-19 Patients
M Klapholz, SR Pentakota, JP Zertuche, M McKenna, W Roque, M Forsberg, J Packer, DS Lal, L Dever |
Open Forum Infectious Diseases | 2021 |
Effect of Convalescent Plasma in Critically Ill Patients With COVID-19: An Observational Study
P Kurtz, C Righy, M Gadelha, FA Bozza, PT Bozza, B Gonçalves, LS Bastos, AM Vale, LM Higa, L Castilho, FL Monteiro, N Charris, F Fialho, R Turon, A Guterres, RL Miranda, CH de Azeredo Lima, V de Caro, MA Prazeres, N Ventura, C Gaspari, F Miranda, PJ da Mata, M Pêcego, S Mateos, ME Lopes, S Castilho, Á Oliveira, C Boquimpani, A Rabello, J Lopes, OC Neto, , A Tanuri, PN Filho, L Amorim |
Frontiers in Medicine | 2021 |
Selecting COVID ‐19 convalescent plasma for neutralizing antibody potency using a high‐capacity SARS‐CoV ‐2 antibody assay
EG Meyer, G Simmons, E Grebe, M Gannett, S Franz, O Darst, CD Germanio, M Stone, P Contestable, A Prichard, R Reik, R Vassallo, P Young, MP Busch, P Williamson, LJ Dumont |
Transfusion | 2021 |
Elevated Rate of HLA Antibodies in Male COVID-19 Convalescent Plasma Donors
JE Juskewitch, JR Stubbs, MJ Gandhi |
Mayo Clinic Proceedings | 2021 |
Impact of the COVID‐19 pandemic on blood supply and demand in the WHO African Region
A Loua, OM Kasilo, JB Nikiema, AS Sougou, S Kniazkov, EA Annan |
Vox Sanguinis | 2021 |
Correlation between SARS‐COV‐2 antibody screening by immunoassay and neutralizing antibody testing
A MendroneJunior, CL Dinardo, SC Ferreira, A Nishya, NA Salles, CA Neto, DT Hamasaki, T Facincani, LB Alves, RR Machado, DB Araujo, EL Durigon, V Rocha, EC Sabino |
Transfusion | 2021 |
Early mortality benefit with COVID‐19 convalescent plasma: a matched control study
AG Shenoy, AZ Hettinger, SJ Fernandez, J Blumenthal, V Baez |
British Journal of Haematology | 2021 |
Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19: A Randomized Clinical Trial
RL Gottlieb, A Nirula, P Chen, J Boscia, B Heller, J Morris, G Huhn, J Cardona, B Mocherla, V Stosor, I Shawa, P Kumar, AC Adams, JV Naarden, KL Custer, M Durante, G Oakley, AE Schade, TR Holzer, PJ Ebert, RE Higgs, NL Kallewaard, J Sabo, DR Patel, P Klekotka, L Shen, DM Skovronsky |
Journal of the American Medical Association | 2021 |
COVID-19 Transmission, Current Treatment, and Future Therapeutic Strategies
VS Salian, JA Wright, PT Vedell, S Nair, C Li, M Kandimalla, X Tang, EM Porquera, KR Kalari, KK Kandimalla |
Molecular Pharmaceutics | 2021 |
Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults
R Libster, GP Marc, D Wappner, S Coviello, A Bianchi, V Braem, I Esteban, MT Caballero, C Wood, M Berrueta, A Rondan, G Lescano, P Cruz, Y Ritou, VF Viña, DÁ Paggi, S Esperante, A Ferreti, G Ofman, Á Ciganda, R Rodriguez, J Lantos, R Valentini, N Itcovici, A Hintze, ML Oyarvide, C Etchegaray, A Neira, I Name, J Alfonso, RL Castelo, G Caruso, S Rapelius, F Alvez, F Etchenique, F Dimase, D Alvarez, SS Aranda, CS Yanotti, JD Luca, SJ Baglivo, S Laudanno, F Nowogrodzki, R Larrea, M Silveyra, G Leberzstein, A Debonis, J Molinos, M González, E Perez, N Kreplak, SusanaArgüello, L Gibbons, F Althabe, E Bergel, FP Polack |
New England Journal of Medicine | 2021 |
The role of serum specific- SARS-CoV-2 antibody in COVID-19 patients
H Chen, X Zhang, W Liu, M Xue, C Liao, Z Huang, H Hu, B Sun |
International Immunopharmacology | 2021 |
Remdesivir in Coronavirus Disease 2019 (COVID-19) treatment: a review of evidence
HX Lin, S Cho, VM Aravamudan, HY Sanda, R Palraj, JS Molton, I Venkatachalam |
Infection | 2021 |
Risk and Management of Venous Thromboembolism in Patients with COVID-19
N Skeik, JE Smith, L Patel, AK Mirza, JM Manunga, D Beddow |
Annals of Vascular Surgery | 2021 |
The interplay between inflammatory pathways and COVID-19: A critical review on pathogenesis and therapeutic options
S Choudhary, K Sharma, O Silakari |
Microbial Pathogenesis | 2021 |
Controlled trials needed to prove efficacy and safety of convalescent plasma therapy in coronavirus disease 2019
N Hartog, A Holsworth, S Rajasekaran |
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology | 2021 |
SARS-CoV-2 convalescent plasma therapy in pediatric patient after hematopoietic stem cell transplantation
D Balashov, P Trakhtman, A Livshits, I Kovalenko, G Tereshenko, G Solopova, E Petraikina, A Maschan, G Novichkova |
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis | 2021 |
Antibodies at work in the time of severe acute respiratory syndrome coronavirus 2
KV Sajna, S Kamat |
Cytotherapy | 2021 |
Access to and safety of COVID-19 convalescent plasma in the United States Expanded Access Program: A national registry study
JW Senefeld, PW Johnson, KL Kunze, EM Bloch, N van Helmond, MA Golafshar, SA Klassen, AM Klompas, MA Sexton, JC Soto, BJ Grossman, AA Tobian, R Goel, CC Wiggins, KA Bruno, CM van Buskirk, JR Stubbs, JL Winters, A Casadevall, NS Paneth, BH Shaz, MM Petersen, BS Sachais, MR Buras, MA Wieczorek, B Russoniello, LJ Dumont, SE Baker, RR Vassallo, JR Shepherd, PP Young, NC Verdun, P Marks, NR Haley, RF Rea, L Katz, V Herasevich, DA Waxman, ER Whelan, A Bergman, AJ Clayburn, MK Grabowski, KF Larson, JG Ripoll, KJ Andersen, MN Vogt, JJ Dennis, RJ Regimbal, PR Bauer, JE Blair, ZA Buchholtz, MC Pletsch, K Wright, JT Greenshields, MJ Joyner, RS Wright, RE Carter, DL Fairweather, C SoOsman |
PLoS Medicine | 2021 |
Outcome of SARS CoV-2 inpatients treated with convalescent plasma: One-year of data from the Veneto region (Italy) Registry
G Silvestro, P Marson, M Raja, A Cattelan, G Guarnieri, J Monticelli, I Tiberio, A Vianello, G Gandini, G Gessoni, F Fiorin, C Sardella, L Astolfi, M Saia |
European Journal of Internal Medicine | 2021 |
Perplexing Issues for Convalescent Immune Plasma Therapy in COVID-19
O Ozdemir |
Northern Clinics of Istanbul | 2021 |
Efficacy and safety of current treatment interventions for patients with severe COVID‐19 infection: A network meta‐analysis of randomized controlled trials
Q Cheng, G Zhao, J Chen, Q Jia, Z Fang |
Journal of Medical Virology | 2021 |
Impact of Convalescent Plasma Therapy on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Profile in Coronavirus Disease 2019 (COVID-19) Patients
Tang J, Grubbs G, Lee Y, Golding H, Khurana S |
Clinical Infectious Diseases | 2021 |
Blood and blood treatments
Gubler KD, Offner KE, Higham MC, Stephenson LG |
Side Effects of Drugs Annual | 2021 |
Effectiveness and Controversy of Convalescent Plasma Therapy for Coronavirus Disease 2019 Patients
Shu Z, Wu P, Qian Q, Zhou L, Du D, Ding M, Peng T, Fang K |
2021 | |
Fc-engineered antibody therapeutics with improved anti-SARS-CoV-2 efficacy
Yamin R, Jones AT, Hoffmann HH, Schäfer A, Kao KS, Francis RL, Sheahan TP, Baric RS, Rice CM, Ravetch JV, Bournazos S |
Nature | 2021 |
Non-pharmacological treatments for COVID-19: current status and consensus
Pereira AA, de Oliveira Andrade A, de Andrade Palis A, Cabral AM, Barreto CG, de Souza DB, de Paula Silva F, Santos FP, Silva GL, Guimarães JF, de Araújo LA, Nóbrega LR, Mendes LC, Brandão MR, Milagre ST, de Lima Gonçalves V, de Freitas Morales VH, da Conceição Lima V |
Research on Biomedical Engineering | 2021 |
Life after COVID-19: Future directions?
Amin P |
2021 | |
COVID-19 aus Sicht der Hämatologie und Hämostaseologie
Spiekermann K, Subklewe M, Hildebrandt M, Humpe A, von Bergwelt-Baildon M |
2021 | |
Emergency Use of Convalescent Plasma: Perception of the Regulatory Framework from a Clinical Perspective
Möhnle P, Humpe A, Boeck M, Gruetzner S, Hackstein H, Offner R, Hildebrandt M |
Transfusion Medicine and Hemotherapy | 2021 |
Severe Acute Respiratory Syndrome Coronavirus 2 Convalescent Plasma Versus Standard Plasma in Coronavirus Disease 2019 Infected Hospitalized Patients in New York: A Double-Blind Randomized Trial
Bennett-Guerrero E, Romeiser JL, Talbot LR, Ahmed T, Mamone LJ, Singh SM, Hearing JC, Salman H, Holiprosad DD, Freedenberg AT, Carter JA, Browne NJ, Cosgrove ME, Shevik ME, Generale LM, Andrew MA, Nachman S, Fries BC |
Critical Care Medicine | 2021 |
Clinical characteristics of hospitalised patients with COVID-19 and the impact on mortality: a single-network, retrospective cohort study from Pennsylvania state.
Gadhiya KP, Hansrivijit P, Gangireddy M, Goldman JD |
BMJ Open | 2021 |
Functional Antibodies in COVID-19 Convalescent Plasma.
Herman JD, Wang C, Loos C, Yoon H, Rivera J, Dieterle ME, Haslwanter D, Jangra RK, Bortz RH 3rd, Bar KJ, Julg B, Chandran K, Lauffenburger D, Pirofski LA, Alter G |
medRxiv : the preprint server for health sciences | 2021 |
Randomized controlled trial transfusing convalescent plasma as post-exposure prophylaxis against SARS-CoV-2 infection.
Shoham S, Bloch EM, Casadevall A, Hanley D, Lau B, Gebo K, Cachay E, Kassaye SG, Paxton JH, Gerber J, Levine AC, Currier J, Patel B, Allen ES, Anjan S, Appel L, Baksh S, Blair PW, Bowen A, Broderick P, Caputo CA, Cluzet V, Cordisco ME, Cruser D, Ehrhardt S, Forthal D, Fukuta Y, Gawad AL, Gniadek T, Hammel J, Huaman MA, Jabs DA, Jedlicka A, Karlen N, Klein S, Laeyendecker O, Lane K, McBee N, Meisenberg B, Merlo C, Mosnaim G, Park HS, Pekosz A, Petrini J, Rausch W, Shade DM, Shapiro JR, Singleton JR, Sutcliffe C, Thomas DL, Yarava A, Zand M, Zenilman JM, Tobian AAR, Sullivan D |
medRxiv : the preprint server for health sciences | 2021 |
Randomized Controlled Trial of Early Outpatient COVID-19 Treatment with High-Titer Convalescent Plasma.
Sullivan DJ, Gebo KA, Shoham S, Bloch EM, Lau B, Shenoy AG, Mosnaim GS, Gniadek TJ, Fukuta Y, Patel B, Heath SL, Levine AC, Meisenberg BR, Spivak ES, Anjan S, Huaman MA, Blair JE, Currier JS, Paxton JH, Gerber JM, Petrini JR, Broderick PB, Rausch W, Cordisco ME, Hammel J, Greenblatt B, Cluzet VC, Cruser D, Oei K, Abinante M, Hammitt LL, Sutcliffe CG, Forthal DN, Zand MS, Cachay ER, Raval JS, Kassaye SG, Foster EC, Roth M, Marshall CE, Yarava A, Lane K, McBee NA, Gawad AL, Karlen N, Singh A, Ford DE, Jabs DA, Appel LJ, Shade DM, Ehrhardt S, Baksh SN, Laeyendecker O, Pekosz A, Klein SL, Casadevall A, Tobian AAR, Hanley DF |
medRxiv : the preprint server for health sciences | 2021 |
Convalescent Plasma Use in the United States was inversely correlated with COVID-19 Mortality: Did Plasma Hesitancy cost lives?
Casadevall A, Dragotakes Q, Johnson PW, Senefeld JW, Klassen SA, Wright RS, Joyner MJ, Paneth N, Carter RE |
2021 | |
COVID-19 antibody development fueled by HIV-1 bNAb research
Mendoza P, Lorenzi JC, Gaebler C |
Current opinion in HIV and AIDS | 2021 |
SARS-CoV-2 viral load and antibody responses: the case for convalescent plasma therapy
Arturo Casadevall, Michael J. Joyner, Liise-anne Pirofski |
Journal of Clinical Investigation | 2020 |
What are protective antibody responses to pandemic SARS-CoV-2?
Jeffrey P. Henderson |
Journal of Clinical Investigation | 2020 |
Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population
Sabra L. Klein, Andrew Pekosz, Han-Sol Park, Rebecca L. Ursin, Janna R. Shapiro, Sarah E. Benner, Kirsten Littlefield, Swetha Kumar, Harnish Mukesh Naik, Michael Betenbaugh, Ruchee Shrestha, Annie A. Wu, Robert M. Hughes, Imani Burgess, Patrizio Caturegli, Oliver Laeyendecker, Thomas C. Quinn, David J. Sullivan, Shmuel Shoham, Andrew D. Redd, Evan M. Bloch, Arturo Casadevall, Aaron A. R. Tobian |
Journal of Clinical Investigation | 2020 |
Autoinflammatory and autoimmune conditions at the crossroad of COVID-19
Y Rodríguez, L Novelli, M Rojas, MD Santis, Y Acosta-Ampudia, DM Monsalve, C Ramírez-Santana, A Costanzo, WM Ridgway, AA Ansari, ME Gershwin, C Selmi, JM Anaya |
Journal of Autoimmunity | 2020 |
Neurological injuries in COVID-19 patients: direct viral invasion or a bystander injury after infection of epithelial/endothelial cells
SA Azizi, SA Azizi |
Journal of Neurovirology | 2020 |
The role of IgG Fc receptors in antibody-dependent enhancement
S Bournazos, A Gupta, JV Ravetch |
Nature Reviews Immunology | 2020 |
Evaluation of Platelet Responses in Transfusion-Related Acute Lung Injury (TRALI)
EA van der Laan, S van der Velden, L Porcelijn, JW Semple, CE van der Schoot, R Kapur |
Transfusion Medicine Reviews | 2020 |
Pharmaco-Immunomodulatory Therapy in COVID-19
JG Rizk, K Kalantar-Zadeh, MR Mehra, CJ Lavie, Y Rizk, DN Forthal |
Drugs | 2020 |
Understanding the complexities of SARS-CoV2 infection and its immunology: A road to immune-based therapeutics
V Kumar |
International Immunopharmacology | 2020 |
Emerging pharmacological therapies for ARDS: COVID-19 and beyond
S Horie, B McNicholas, E Rezoagli, T Pham, G Curley, D McAuley, C OKane, A Nichol, C dos Santos, PR Rocco, G Bellani, JG Laffey |
Intensive Care Medicine | 2020 |
Convalescent Plasma against COVID-19: A Broad-Spectrum Therapeutic Approach for Emerging Infectious Diseases
M Thijssen, T Devos, HS Ejtahed, S Amini-Bavil-Olyaee, AA Pourfathollah, MR Pourkarim |
Microorganisms | 2020 |
Antibody-dependent enhancement and COVID-19: Moving toward acquittal
EJ Yager |
Clinical Immunology | 2020 |
Convalescent plasma to treat critically ill patients with COVID-19: framing the need for randomised clinical trials
M Shankar-Hari, L Estcourt, H Harvala, D Roberts, DK Menon, M Shankar-Hari, L Estcourt, H Harvala, D Roberts, DK Menon |
Critical Care | 2020 |
Clinical predictors of donor antibody titre and correlation with recipient antibody response in a COVID‐19 convalescent plasma clinical trial
ML Madariaga, JJ Guthmiller, S Schrantz, MO Jansen, C Christensen, M Kumar, M Prochaska, G Wool, A DurkinCelauro, WH Oh, L Trockman, J Vigneswaran, R Keskey, DG Shaw, H Dugan, NY Zheng, M Cobb, H Utset, J Wang, O Stovicek, C Bethel, S Matushek, M Giurcanu, KG Beavis, D Sabato, D Meltzer, MK Ferguson, JP Kress, K Shanmugarajah, JB Matthews, JF Fung, PC Wilson, JC Alverdy, JS Donington |
Journal of Internal Medicine | 2020 |
A Retrospective Study on the Effects of Convalescent Plasma Therapy in 24 Patients Diagnosed with COVID-19 Pneumonia in February and March 2020 at 2 Centers in Wuhan, China
S Huang, C Shen, C Xia, X Huang, Y Fu, L Tian |
Medical science monitor : international medical journal of experimental and clinical research | 2020 |
Convalescent Plasma Therapy for Management of COVID-19: Perspectives and Deployment in the Current Global Pandemic N Samad, TE Sodunke, HA Banna, A Sapkota, AN Fatema, K Iskandar, D Jahan, TC Hardcastle, T Nusrat, TS Chowdhury, M Haque |
Risk Management and Healthcare Policy | 2020 |
Safety Update
MJ Joyner, KA Bruno, SA Klassen, KL Kunze, PW Johnson, ER Lesser, CC Wiggins, JW Senefeld, AM Klompas, DO Hodge, JR Shepherd, RF Rea, ER Whelan, AJ Clayburn, MR Spiegel, SE Baker, KF Larson, JG Ripoll, KJ Andersen, MR Buras, MN Vogt, V Herasevich, JJ Dennis, RJ Regimbal, PR Bauer, JE Blair, CM van Buskirk, JL Winters, JR Stubbs, N van Helmond, BP Butterfield, MA Sexton, JC Soto, NS Paneth, NC Verdun, P Marks, A Casadevall, DL Fairweather, RE Carter, RS Wright |
Mayo Clinic Proceedings | 2020 |
SARS-CoV-2 Antibody Avidity Responses in COVID-19 Patients and Convalescent Plasma Donors
SE Benner, EU Patel, O Laeyendecker, A Pekosz, K Littlefield, Y Eby, RE Fernandez, J Miller, CS Kirby, M Keruly, E Klock, OR Baker, HA Schmidt, R Shrestha, I Burgess, TS Bonny, W Clarke, P Caturegli, D Sullivan, S Shoham, TC Quinn, EM Bloch, A Casadevall, AA Tobian, AD Redd |
The Journal of Infectious Diseases | 2020 |
Convalescent plasma for pediatric patients with SARS‐CoV‐2‐associated acute respiratory distress syndrome
C Diorio, EM Anderson, KO McNerney, EC Goodwin, JC Chase, MJ Bolton, CP Arevalo, ME Weirick, S Gouma, LA Vella, SE Henrickson, K Chiotos, JC Fitzgerald, TJ Kilbaugh, AR John, AM Blatz, MP Lambert, KE Sullivan, MR Tartaglione, D Zambrano, M Martin, JH Lee, P Young, D Friedman, DA SesokPizzini, SE Hensley, EM Behrens, H Bassiri, DT Teachey |
Pediatric Blood & Cancer | 2020 |
Convalescent Plasma in the Treatment of Severe COVID-19: A Systematic Review and Meta-Analysis
X ZHANG, , F PANG, Y DU, Q YUAN, M SHI, J LIU, H MA, B LI |
2020 | |
Mortality reduction in 46 severe Covid-19 patients treated with hyperimmune plasma. A proof of concept single arm multicenter trial
C Perotti, F Baldanti, R Bruno, CD Fante, E Seminari, S Casari, E Percivalle, C Glingani, V Musella, M Belliato, M Garuti, F Meloni, M Frigato, AD Sabatino, C Klersy, GD Donno, M Franchini, C plasma task force |
Haematologica | 2020 |
Convalescent plasma for administration of passive antibodies against viral agents
GD Minno, PM Mannucci, JW Ironside, CF Perno, L Gürtler, L Aledort |
Haematologica | 2020 |
Recruitment Strategy for Potential COVID-19 Convalescent Plasma Donors
KJ Andersen, SA Klassen, KF Larson, JG Ripoll, JW Senefeld, AJ Clayburn, JR Shepherd, AS Tseng, CC Wiggins, BM Murphy, SK Ford, CP Johnson, AD Miller, SE Baker, RS Wright, JL Winters, JR Stubbs, MJ Joyner, CM van Buskirk |
Mayo Clinic Proceedings | 2020 |
Emerging treatment strategies for COVID-19 infection
M Gavriatopoulou, I Ntanasis-Stathopoulos, E Korompoki, D Fotiou, M Migkou, IG Tzanninis, T Psaltopoulou, E Kastritis, E Terpos, MA Dimopoulos |
Clinical and Experimental Medicine | 2020 |
Antibody Binding to SARS-CoV-2 S Glycoprotein Correlates with but Does Not Predict Neutralization
S Ding, A Laumaea, M Benlarbi, G Beaudoin-Bussières, R Gasser, H Medjahed, M Pancera, L Stamatatos, A McGuire, R Bazin, A Finzi |
Viruses | 2020 |
A single center cohort of 40 severe COVID-19 patients who were treated with convalescent plasma
A GEMİCİ, H BİLGEN, C ERDOĞAN, A KANSU, O OLMUŞÇELİK, HS BEKÖZ, R DİNLEYİCİ, A MERT, ÖG SEVİNDİK |
2020 | |
Decline of Humoral Responses against SARS-CoV-2 Spike in Convalescent Individuals
G Beaudoin-Bussières, A Laumaea, SP Anand, J Prévost, R Gasser, G Goyette, H Medjahed, J Perreault, T Tremblay, A Lewin, L Gokool, C Morrisseau, P Bégin, C Tremblay, V Martel-Laferrière, DE Kaufmann, J Richard, R Bazin, A Finzi, DD Ho, SP Goff |
mBio | 2020 |
Convalescent plasma appears efficacious and safe in COVID-19
D Khulood, MS Adil, R Sultana, Nimra |
Therapeutic advances in infectious disease | 2020 |
Three patients with X-linked agammaglobulinemia hospitalized for COVID-19 improved with convalescent plasma
H Jin, JC Reed, ST Liu, H Ho, JP Lopes, NB Ramsey, O Waqar, F Rahman, JA Aberg, NM Bouvier, C Cunningham-Rundles, ST Liu, HM Lin, A Abrams-Downey, KP Cascetta, AE Glatt, SC Koshy, E Kojic, DS Mazo, D Perlman, S Rudolph, J Steinberg, T Schneider, I Baine, A Wajnberg, JP Gumprecht, F Rahman, D Rodriguez, C Sanky, A Dupper, DR Altman, F Krammer, DR Mendu, A Firpo-Betancourt, C Cordon-Cardo, JS Jhang, SA Arinsberg, DL Reich, JA Aberg, NM Bouvier |
The Journal of Allergy and Clinical Immunology: In Practice | 2020 |
Treatment of COVID-19 with convalescent plasma: lessons from past coronavirus outbreaks
DJ Wooding, H Bach |
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2020 |
Convalescent serum therapy for COVID-19: A 19th century remedy for a 21st century disease
D Montelongo-Jauregui, T Vila, AS Sultan, MA Jabra-Rizk, RE Dutch |
PLoS pathogens | 2020 |
Earlier the better: convalescent plasma
AA Tobian, BH Shaz |
Blood | 2020 |
International Survey of Trials of Convalescent Plasma to Treat COVID-19 Infection
M Murphy, L Estcourt, J Grant-Casey, S Dzik |
Transfusion Medicine Reviews | 2020 |
Clinical efficacy of convalescent plasma for treatment of COVID-19 infections: Results of a multicenter clinical study
H Abolghasemi, P Eshghi, AM Cheraghali, AA Fooladi, FB Moghaddam, S Imanizadeh, MM Maleki, M Ranjkesh, M Rezapour, A Bahramifar, B Einollahi, MJ Hosseini, NJ Jafari, M Nikpouraghdam, N Sadri, M Tazik, S Sali, S Okati, E Askari, P Tabarsi, J Aslani, E Sharifipour, MH Jarahzadeh, N Khodakarim, M Salesi, R Jafari, S Shahverdi |
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis | 2020 |
Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review
V Piechotta, KL Chai, SJ Valk, C Doree, I Monsef, EM Wood, A Lamikanra, C Kimber, Z McQuilten, C So-Osman, LJ Estcourt, N Skoetz |
Cochrane Database of Systematic Reviews | 2020 |
Transfusion Service Response to the COVID-19 Pandemic
E Gehrie, CA Tormey, KW Sanford |
American Journal of Clinical Pathology | 2020 |
Improved clinical symptoms and mortality among patients with severe or critical COVID-19 after convalescent plasma transfusion
X Xia, K Li, L Wu, Z Wang, M Zhu, B Huang, J Li, Z Wang, W Wu, M Wu, W Li, L Li, Y Cai, B Bosco, A Zhong, X Liu, T Lv, Z Gan, G Chen, Y Pan, C Liu, K Zhang, X Xu, C Wang, Q Wang |
Blood | 2020 |
Clinical use of Convalescent Plasma in the COVID‐19 pandemic: a transfusion‐focussed gap analysis with recommendations for future research priorities
AZ AlRiyami, R Schäfer, K Berg, EM Bloch, LJ Estcourt, R Goel, S Hindawi, CD Josephson, K Land, ZK McQuilten, SL Spitalnik, EM Wood, DV Devine, C SoOsman |
Vox Sanguinis | 2020 |
A Review on Currently Available Potential Therapeutic Options for COVID-19 SO Moghadam |
International journal of general medicine | 2020 |
Host-pathogen interaction in COVID-19: Pathogenesis, potential therapeutics and vaccination strategies
PM Varghese, AG Tsolaki, H Yasmin, A Shastri, J Ferluga, M Vatish, T Madan, U Kishore |
Immunobiology | 2020 |
COVID-19 treatments and pathogenesis including anosmia in K18-hACE2 mice
J Zheng, LY Wong, K Li, AK Verma, ME Ortiz, C Wohlford-Lenane, MR Leidinger, CM Knudson, DK Meyerholz, PB McCray, S Perlman |
Nature | 2020 |
The Assessment of Convalescent Plasma Efficacy against COVID-19
A Casadevall, BJ Grossman, JP Henderson, MJ Joyner, S Shoham, L Pirofski, N Paneth |
The American Journal of Medicine | 2020 |
COVID-19 Therapeutic Options Under Investigation
M Kaddoura, M AlIbrahim, G Hijazi, N Soudani, A Audi, H Alkalamouni, S Haddad, A Eid, H Zaraket |
Frontiers in pharmacology | 2020 |
Convalescent Plasma Therapy for COVID-19: State of the Art
D Focosi, AO Anderson, JW Tang, M Tuccori |
Clinical microbiology reviews | 2020 |
Neutralizing antibodies against SARS-CoV-2: current understanding, challenge and perspective
Y Huang, H Sun, H Yu, S Li, Q Zheng, N Xia |
2020 | |
A retrospective study assessing the characteristics of COVID‐19 convalescent plasma donors and donations
CD Fante, M Franchini, F Baldanti, E Percivalle, C Glingani, G Marano, C Mengoli, C Mortellaro, G Viarengo, C Perotti, GM Liumbruno |
Transfusion | 2020 |
Skin and gastrointestinal symptoms in COVID-19
P Ciechanowicz, K Lewandowski, E Szymańska, M Kaniewska, G Rydzewska, I Walecka |
PRZ GASTROENTEROL | 2020 |
Pragmatic Recommendations for Therapeutics of Hospitalized COVID-19 Patients in Low- and Middle-Income Countries
VU Shetty, BJ Brotherton, A Achilleos, KM Akrami, LM Barros, W Checkley, N Cobb, S Maximous, D Misango, C Park, S Taran, BW Lee |
The American journal of tropical medicine and hygiene | 2020 |
Convalescent Plasma Transfusion for the Treatment of COVID-19—Experience from Poland: A Multicenter Study
A Moniuszko-Malinowska, P Czupryna, D Zarębska-Michaluk, K Tomasiewicz, S Pancewicz, M Rorat, A Dworzańska, K Sikorska, B Bolewska, B Lorenc, A Chciałowski, D Kozielewicz, B Oczko-Grzesik, A Szymanek-Pasternak, B Szetela, M Figlerowicz, M Rogalska, I Zaleska, R Flisiak |
Journal of Clinical Medicine | 2020 |
A Review of Treatment of Coronavirus Disease 2019 (COVID-19): Therapeutic Repurposing and Unmet Clinical Needs
PL Chen, NY Lee, CT Cia, WC Ko, PR Hsueh |
Frontiers in pharmacology | 2020 |
COVID-19 Treatment at a Glance
H Arikan, D Karadogan, FT Akyil, A Yuksel, ZN Toreyin, CG Gurkan, F Marim, TS Eyuboglu, N Emiralioglu, TR Gursoy, I Serifoglu, A Sandal, A Oncel, B Er, N Kose, D Esendagli, M Hizal, AB Er, FE Gunaydin, I Kaya, H Ozakinci, UO Sertcelik, HC Tuglu, NA Ozurk, O Ataoglu, AC Cakir, H Toptay, M Ercelik, E Develi, S Celik, FG Karakas, H Yildirim, DK Guven, N Cetin, SN Kucukyurt, MF Elverisli, PY Gulhan, M Akgun |
2020 | |
Safety and efficacy of convalescent plasma therapy in severely and critically ill patients with COVID-19: a systematic review with meta-analysis
L Wenjing, F Yuanzheng, JY Li, LV Tang, H Yu |
Aging | 2020 |
A multicenter randomized trial to assess the efficacy of CONvalescent plasma therapy in patients with Invasive COVID-19 and acute respiratory failure treated with mechanical ventilation: the CONFIDENT trial protocol
B Misset, E Hoste, AF Donneau, D Grimaldi, G Meyfroidt, M Moutschen, V Compernolle, A Gothot, D Desmecht, M Garigliany, T Najdovski, PF Laterre |
BMC Pulmonary Medicine | 2020 |
A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working against nCoV (DAWn-Plasma) trial
T Devos, T Geukens, A Schauwvlieghe, KK Ariën, C Barbezange, M Cleeren, V Compernolle, N Dauby, D Desmecht, D Grimaldi, BN Lambrecht, A Luyten, P Maes, M Moutschen, M Romano, L Seyler, MT Nevessignsky, K Vandenberghe, J van Griensven, G Verbeke, E Vlieghe, JC Yombi, L Liesenborghs, P Verhamme, G Meyfroidt |
Trials | 2020 |
A serological assay to detect SARS-CoV-2 antibodies in at-home collected finger-prick dried blood spots
DG Karp, K Danh, NF Espinoza, D Seftel, PV Robinson, C Tsai |
Scientific Reports | 2020 |
Medical management of COVID-19 clinic
N Mehta, R Qiao |
Journal of Biomedical Research | 2020 |
Cyanoamidine Cyclization Approach to Remdesivir’s Nucleobase
RR Knapp, V Tona, T Okada, R Sarpong, NK Garg |
Organic letters | 2020 |
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd |
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology | 2009 |
Abnormal antibodies to self-carbohydrates in SARS-CoV-2 infected patients
Dorothy L Butler, Jeffrey C Gildersleeve |
||
Convalescent plasma therapy in patients with COVID-19
F Altuntas, N Ata, TN Yigenoglu, S Bascı, MS Dal, S Korkmaz, S Namdaroglu, A Basturk, T Hacıbekiroglu, MH Dogu, İ Berber, K Dal, K Kınık, İ Haznedaroglu, FM Yılmaz, İ Kılıç, S Demircioğlu, A Yosunkaya, MA Erkurt, B Turgut, M Caglayan, O Celik |
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis | 2021 |
Identification and Tracking of Antiviral Drug Combinations
A Ianevski, R Yao, S Biza, E Zusinaite, A Mannik, G Kivi, A Planken, K Kurg, EM Tombak, M Ustav, N Shtaida, E Kulesskiy, E Jo, J Yang, H Lysvand, K Løseth, V Oksenych, PA Aas, T Tenson, A Vitkauskienė, MP Windisch, MH Fenstad, SA Nordbø, M Ustav, M Bjørås, DE Kainov |
Viruses | 2020 |
Evidence-based management of COVID-19 in cancer patients: Guideline by the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)
N Giesen, R Sprute, M Rüthrich, Y Khodamoradi, SC Mellinghoff, G Beutel, C Lueck, M Koldehoff, M Hentrich, M Sandherr, M von Bergwelt-Baildon, HH Wolf, HH Hirsch, B Wörmann, OA Cornely, P Köhler, E Schalk, M von Lilienfeld-Toal |
European Journal of Cancer | 2020 |
Convalescent Plasma Therapy in Four Critically Ill Pediatric Patients With Coronavirus Disease 2019: A Case Series
SP Schwartz, P Thompson, M Smith, DM Lercher, CA Rimland, L Bartelt, YA Park, S Weiss, AJ Markmann, R Raut, L Premkumar, JA Kuruc, Z Willis |
2020 | |
Convalescent Plasma Therapy for Coronavirus Disease 2019
JY Choi |
Infection & Chemotherapy | 2020 |
Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection
Z Maghbooli, MA Sahraian, M Ebrahimi, M Pazoki, S Kafan, HM Tabriz, A Hadadi, M Montazeri, M Nasiri, A Shirvani, MF Holick, M Adrish |
PloS one | 2020 |
The use of mesenchymal stromal cells in the treatment of coronavirus disease 2019
MA Canham, JD Campbell, JC Mountford |
Journal of Translational Medicine | 2020 |
Factors Associated with Good Patient Outcomes Following Convalescent Plasma in COVID-19: A Prospective Phase II Clinical Trial
D Ibrahim, L Dulipsingh, L Zapatka, R Eadie, R Crowell, K Williams, DB Wakefield, L Cook, J Puff, SA Hussain |
Infectious Diseases and Therapy | 2020 |
Convalescent Plasma for the Treatment of Severe COVID‐19 Infection in Cancer Patients
D Tremblay, C Seah, T Schneider, S Bhalla, J Feld, L Naymagon, B Wang, V Patel, T Jun, T Jandl, F Rahman, ST Liu, JA Aberg, N Bouvier |
Cancer Medicine | 2020 |
Screening for SARS‐CoV ‐2 antibodies in convalescent plasma in Brazil: Preliminary lessons from a voluntary convalescent donor program
S Wendel, JM Kutner, R Machado, R FontãoWendel, C Bub, R Fachini, A Yokoyama, G Candelaria, A Sakashita, R Achkar, N Hamerschlak, P Scuracchio, M Amaral, MD Ben, D Araujo, C Soares, A Camargo, E Kallás, E Durigon, LF Reis, LV Rizzo |
Transfusion | 2020 |
Probiotics and Coronavirus disease 2019: think about the link
SK Angurana, A Bansal |
British Journal of Nutrition | 2020 |
COVID-19: FAQs in Pediatric Cardiac Surgery—A Sequel
E Levy, J Blumenthal, K Chiotos, EH Stephens, JA Dearani |
World journal for pediatric & congenital heart surgery | 2020 |
A Review on Current Repurposing Drugs for the Treatment of COVID-19: Reality and Challenges
S Hossen, A Barek, N Jahan, MS Islam |
2020 | |
Convalescent plasma as a treatment modality for coronavirus disease 2019 in Sudan
MO Hassan, AA Osman, HE Elbasit, HE Hassan, H Rufai, MM Satti, M Elnegoumi, R Idris, A Musa, AH Ali, SA Zroog, AD Altayb, A Khairy, M Allam, AT Abdelhalim |
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis | 2020 |
Convalescent plasma therapy for coronavirus infection: experience from MERS and application in COVID-19
JA Al-Tawfiq, Y Arabi |
Human Vaccines & Immunotherapeutics | 2020 |
Challenges in the Management of Sickle Cell Disease During SARS-CoV-2 Pandemic
F Alsayegh, SA Mousa |
Clinical and Applied Thrombosis/Hemostasis | 2020 |
Convalescent plasma for COVID-19: the risk of pulmonary embolism should not be underestimated!
F Sanfilippo, VL Rosa, F Oliveri, M Astuto |
Critical Care | 2020 |
Treatment of Coronavirus Disease 2019 Patients with Convalescent Plasma Reveals a Signal of Significantly Decreased Mortality
E Salazar, PA Christensen, EA Graviss, DT Nguyen, B Castillo, J Chen, BV Lopez, TN Eagar, X Yi, P Zhao, J Rogers, A Shehabeldin, D Joseph, C Leveque, RJ Olsen, DW Bernard, J Gollihar, JM Musser |
The American Journal of Pathology | 2020 |
Hospitalized COVID-19 Patients Treated With Convalescent Plasma in a Mid-size City in The Mid West
William R Hartman, Aaron S Hess, Joseph P Connor |
Research square | 2020 |
Rethinking Gain-of-Function Experiments in the Context of the COVID-19 Pandemic
MJ Imperiale, A Casadevall |
mBio | 2020 |
Immunotherapy for SARS-CoV-2: potential opportunities
M Pashaei, N Rezaei |
Expert Opinion on Biological Therapy | 2020 |
Guidelines for COVID-19 Management in Hematopoietic Cell Transplantation and Cellular Therapy Recipients
A Waghmare, MZ Abidi, M Boeckh, RF Chemaly, S Dadwal, ZE Boghdadly, M Kamboj, GA Papanicolaou, SA Pergam, Z Shahid |
Biology of Blood and Marrow Transplantation | 2020 |
Hospitalized COVID-19 Patients treated with Convalescent Plasma in a Mid-size City in the Midwest
William R Hartman, Aaron S Hess, Joseph P Connor |
Research square | 2020 |
Passive immunotherapy with convalescent plasma against COVID-19? What about the evidence base and clinical trials?
O Garraud |
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis | 2020 |
Therapeutic plasma exchange in adults with severe COVID-19 infection
F Khamis, I Al-Zakwani, SA Hashmi, SA Dowaiki, MA Bahrani, N Pandak, HA Khalili, Z Memish |
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2020 |
Investigational Therapies for the Treatment of COVID-19: Updates from Ongoing Clinical Trials
A Abrams-Downey, J Saabiye, M Vidaurrazaga |
European Urology Focus | 2020 |
Use of convalescent plasma in hospitalized patients with COVID-19: case series
L Hegerova, TA Gooley, KA Sweerus, C Maree, N Bailey, M Bailey, V Dunleavy, K Patel, K Alcorn, R Haley, JM Johnsen, BA Konkle, AC Lahti, ML Alexander, JD Goldman, A Lipke, S Lim, MD Sullivan, JS Pauk, JM Pagel |
Blood | 2020 |
Convalescent plasma – this is no time for competition
A Farrugia, J MacPherson, MP Busch |
Transfusion | 2020 |
A Narrative Review of Emerging Therapeutics for COVID-19
Willis VC, Arriaga Y, Weeraratne D, Reyes F, Jackson GP |
2020 | |
Rekonvaleszentenplasma zur Behandlung von schwerem COVID-19: Rationale und Design einer randomisierten, offenen klinischen Studie von Rekonvaleszentenplasma verglichen mit bestmöglicher supportiver Behandlung (CAPSID-Studie)
Körper S, Jahrsdörfer B, Appl T, Klüter H, Seifried E, Schrezenmeier H |
2020 | |
COVID-19 convalescent plasma treatment of moderate and severe cases of SARS-CoV-2 infection: A multicenter interventional study
Alsharidah S, Ayed M, Ameen RM, Alhuraish F, Rouheldeen NA, Alshammari FR, Embaireeg A, Almelahi M, Adel M, Dawoud ME, Aljasmi MA, Alshammari N, Alsaeedi A, Al-Adsani W, Arian H, Awad H, Alenezi HA, Alzafiri A, Gouda EF, Almehanna M, Alqahtani S, Alshammari A, Askar MZ |
International Journal of Infectious Diseases | 2020 |
Actualización de la Declaración de consenso en medicina critica para la atención multidisciplinaria del paciente con sospecha o confirmación diagnóstica de COVID-19
Accini Mendoza JL, Nieto Estrada VH, Beltrán López N, Ramos Bolaños E, Molano Franco D, Dueñas Castell C, Valencia Moreno AA, Alarcón Amaya IC, Serna Flórez J, Gil Valencia BA, Pizarro C, Zabaleta Polo YM, Chica Meza CL |
Acta Colombiana de Cuidado Intensivo | 2020 |
Anti-SARS-CoV-2 spike antibodies are stable in convalescent plasma when stored at 4° Celsius for at least 6 weeks.
Stadlbauer D, Baine I, Amanat F, Jiang K, Lally K, Krammer F, Jhang JS, Arinsburg SA |
Transfusion | 2020 |
Convalescent plasma for COVID‐19: Back to the future
Roberts DJ, Miflin G, Estcourt L |
Transfusion Medicine | 2020 |
Guidance for the procurement of COVID‐19 convalescent plasma: differences between high‐ and low‐middle‐income countries
Bloch EM, Goel R, Wendel S, Burnouf T, Al\u2010Riyami AZ, Ang AL, DeAngelis V, Dumont LJ, Land K, Lee C, Oreh A, Patidar G, Spitalnik SL, Vermeulen M, Hindawi S, Van den Berg K, Tiberghien P, Vrielink H, Young P, Devine D, So \u2013 Osman C |
Vox Sanguinis | 2020 |
Convalescent plasma is a clutch at straws in COVID‐19 management! A systematic review and meta‐analysis
Sarkar S, Soni KD, Khanna P |
Journal of Medical Virology | 2020 |
Supply and demand for plasma‐derived medicinal products ‐ A critical reassessment amid the COVID‐19 pandemic
Hartmann J, Klein HG |
Transfusion | 2020 |
A consideration of convalescent plasma and plasma derivatives in the care of Severely-ill patients with COVID-19.
Lung T, Kazatchkine MD, Risch L, Risch M, Nydegger UE |
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis | 2020 |
Treatment of Severe COVID-19 with Convalescent Plasma in the Bronx, NYC.
Yoon HA, Bartash R, Gendlina I, Rivera J, Nakouzi A, Bortz RH 3rd, Wirchnianski AS, Paroder M, Fehn K, Serrano-Rahman L, Babb R, Sarwar UN, Haslwanter D, Laudermilch E, Florez C, Dieterle ME, Jangra RK, Fels JM, Tong K, Mariano MC, Vergnolle O, Georgiev GI, Herrera NG, Malonis RJ, Quiroz JA, Morano NC, Krause GJ, Sweeney JM, Cowman K, Allen S, Annam J, Applebaum A, Barboto D, Khokhar A, Lally BJ, Lee A, Lee M, Malaviya A, Sample R, Yang XA, Li Y, Ruiz R, Thota R, Barnhill J, Goldstein DY, Uehlinger J, Garforth SJ, Almo SC, Lai JR, Gil MR, Fox AS, Chandran K, Wang T, Daily JP, Pirofski LA |
medRxiv : the preprint server for health sciences | 2020 |
A SARS-CoV-2 serological assay to determine the presence of blocking antibodies that compete for human ACE2 binding.
Byrnes JR, Zhou XX, Lui I, Elledge SK, Glasgow JE, Lim SA, Loudermilk R, Chiu CY, Wilson MR, Leung KK, Wells JA |
medRxiv : the preprint server for health sciences | 2020 |
Comparative performance of five commercially available serologic assays to detect antibodies to SARS-CoV-2 and identify individuals with high neutralizing titers.
Patel EU, Bloch EM, Clarke W, Hsieh YH, Boon D, Eby Y, Fernandez RE, Baker OR, Keruly M, Kirby CS, Klock E, Littlefield K, Miller J, Schmidt HA, Sullivan P, Piwowar-Manning E, Shrestha R, Redd AD, Rothman RE, Sullivan D, Shoham S, Casadevall A, Quinn TC, Pekosz A, Tobian AAR, Laeyendecker O |
medRxiv : the preprint server for health sciences | 2020 |
Abnormal antibodies to self-carbohydrates in SARS-CoV-2 infected patients.
Butler DL, Gildersleeve JC |
bioRxiv : the preprint server for biology | 2020 |
Quantifying absolute neutralization titers against SARS-CoV-2 by a standardized virus neutralization assay allows for cross-cohort comparisons of COVID-19 sera
Oguntuyo KY, Stevens CS, Hung CT, Ikegame S, Acklin JA, Kowdle SS, Carmichael JC, Chiu HP, Azarm KD, Haas GD, Amanat F, Klingler J, Baine I, Arinsburg S, Bandres JC, Siddiquey MN, Schilke RM, Woolard MD, Zhang H, Duty AJ, Kraus TA, Moran TM, Tortorella D, Lim JK, Gamarnik AV, Hioe CE, Zolla-Pazner S, Ivanov SS, Kamil JP, Krammer F, Lee B |
2020 | |
A patient affected by critical COVID-19 pneumonia, successfully treated with convalescent plasma
Einollahi B, Cegolon L, Abolghasemi H, Imanizadeh S, Bahramifar A, Zhao S, Jafari R, Javanbakht M |
Transfusion and Apheresis Science | 2020 |